category,datetime,headline,id,image,related,source,summary,url
company,1628869683,Here's Why You Should Retain Abiomed (ABMD) Stock for Now,69658226,https://s.yimg.com/uu/api/res/1.2/Bwjibxk8IIsM7dLPsV1mcQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08380da297340a988e9902fee4e753cb,ABMD,Yahoo,Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.,https://finnhub.io/api/news?id=9640bf8784bb309ae458c6f1e21e5446b2fc9a2e0c3b415c906e117b927b99a7
company,1628785980,Abiomed Inc. stock outperforms market on strong trading day,69659345,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.72% higher to $322.17 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=cf838af159113a00da00ecb139f2bed88f076adc32a736b8cb09230636e7c3b2
company,1628699520,Abiomed Inc. stock underperforms Wednesday when compared to competitors,69659346,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 3.85% to $319.88 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=9fc6f844b22dc5e6e0934dbd2fef89b5174fd97bc2f9e43cf97dac1e456c3da5
company,1628685540,"Ownership Capital B.V. Buys Abiomed Inc, ResMed Inc, Maravai LifeSciences Holdings Inc, Sells Visa Inc",69614353,,ABMD,GuruFocus,,https://finnhub.io/api/news?id=74af335123be830ab5c4df95614cf320f44c62c1b190589e42707b3504e6e83f
company,1628684160,"Abiomed Inc (ABMD) Chairman, President, CEO Michael R Minogue Sold $11 million of Shares",69615001,,ABMD,GuruFocus,,https://finnhub.io/api/news?id=073e552f8517824e2118ac0fefcd0c3a8a623a31dbb253266938b703d004741e
company,1628613180,Abiomed Inc. stock underperforms Tuesday when compared to competitors,69659347,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 4.02% to $332.70 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=0d4eb48f7d60a8075db4451f0421c6e9c330a0e22c2691a9b9516c4eeec20dcf
company,1628567820,U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.46% By Investing.com,69614368,https://i-invdn-com.investing.com/news/LYNXMPEB4G09M_L.jpg,ABMD,Investing.com,U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.46%,https://finnhub.io/api/news?id=b8817799f0379d4c66f616078ebff54506e0629738db787d405b32cb0332cb91
company,1628526780,Abiomed Inc. stock outperforms competitors on strong trading day,69659348,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.22% higher to $346.65 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=c404f610800adc5fc5883ce67327ac2dedb6fa255191231b3e3aac916e533a68
company,1628505240,"Commit To Buy ABIOMED At $290, Earn 7.8% Annualized Using Options",69600246,,ABMD,Stock Options Channel,"Staff article entitled Commit To Buy ABIOMED At $290, Earn 7.8% Annualized Using Options, about stock options, from Stock Options Channel.",https://finnhub.io/api/news?id=4aa6c6cdac0a75da336192d35ca578252e1a1a93aea08fe63f2843a582630cd3
company,1628499120,Abiomed dips as traders circulate FDA 'Medsun' report,69580354,,ABMD,Thefly.com,Shares of Abiomed are dow... ABMD,https://finnhub.io/api/news?id=fcd8f139b80b760af04470cb5d4788c0cc0d43b488e5ad0f9c415ec6a0002fa7
company,1628326801,"The CDC reversal on masks changed the way companies view the delta variant, earnings calls show",69567071,https://image.cnbcfm.com/api/v1/image/106881921-1620829789823-gettyimages-1222842974-POST-COVID-OFFICE.jpg?v=1620829800,ABMD,CNBC,Companies have been talking more about the Covid delta variant after new cases accelerated in the U.S. and the CDC reversed its mask guidance.,https://finnhub.io/api/news?id=9e63a74754608b788e88fcaa3ad6fa15168b8b09e43702ad1ca08cedfca05ee4
company,1628267580,Abiomed Inc. stock underperforms Friday when compared to competitors,69554677,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 0.85% to $345.88 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=b4b98595eb24e3f5cc21dfd578a7780e201ee7b46d4dee161bf53286275aa625
company,1628241360,"Abiomed Inc (ABMD) Chairman, President, CEO Michael R Minogue Sold $8.5 million of Shares",69563707,,ABMD,GuruFocus,,https://finnhub.io/api/news?id=82499ee47228b0377dceb77dd5d5f48bc0cf026f3cec20bf6bfa92eadd709ed1
company,1628229780,Abiomed price target raised to $410 from $360 at Deutsche Bank,69543884,,ABMD,Thefly.com,Deutsche Bank analyst Pit... ABMD,https://finnhub.io/api/news?id=6f58078215cb037a511855fd91bbaf05f7bea7a6669009998fa1cc248e6f6f56
company,1628182865,"ABIOMED, inc (ABMD) Q1 2022 Earnings Call Transcript",69528207,,ABMD,Yahoo,"This is Todd Trapp, Vice President and Chief Financial Officer and I'm here with Mike Minogue, Abiomed's Chairman, President and Chief Executive Officer.  The format for today's call will be as follows: first, Mike will discuss first quarter business and operational highlights, and then I will review our financial results, which were outlined in our press release.",https://finnhub.io/api/news?id=fc9eb326cb6821776519b5973b1678c27a890808a7732d86b00d69e0f113a5e2
company,1628181180,"Abiomed Inc. stock rises Thursday, outperforms market",69538989,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 5.33% to $348.86 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=c6d68b96c1d354bf2a731d2214c0780f2822e3d0acce2eb38dc42ad08146fd71
company,1628180404,"Abiomed's (ABMD) Q1 Earnings and Revenues Beat, Margins Up",69525602,https://s.yimg.com/uu/api/res/1.2/MrjlMiAMmnHXIs4gVXDT2w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bc2d2f7d27a42f62f502c2135b92e0d4,ABMD,Yahoo,Abiomed's (ABMD) strength in Impella product revenues drives its Q1 top line.,https://finnhub.io/api/news?id=086fa384484384b862cdafe030436c43941e0f22c535178ea9284707b300b483
company,1628170687,"Abiomed, Inc. (ABMD) CEO Mike Minogue on Q1 2022 Results - Earnings Call Transcript",69525050,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,ABMD,SeekingAlpha,"Abiomed, Inc. (NASDAQ:ABMD) Q1 2022 Earnings Conference Call August 05, 2021 08:00 AM ET Company Participants Todd Trapp - Vice President and Chief Financial Officer Mike Minogue -...",https://finnhub.io/api/news?id=b39fdb0ad67707ed3aed6090dd2892b19464f84af362c33a16e586e5a88ed8c6
company,1628124051,"Abiomed, Inc. 2022 Q1 - Results - Earnings Call Presentation",69508389,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,ABMD,SeekingAlpha,"The following slide deck was published by Abiomed, Inc.",https://finnhub.io/api/news?id=4acb887c811682fd71acfc78a33cbb07e128a175054ef7d30e121f23e3524d99
company,1628117710,Abiomed (ABMD) Beats Q1 Earnings and Revenue Estimates,69505564,https://s.yimg.com/uu/api/res/1.2/M2z0wFqvnPw7eaLU0tPuyQ--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85,ABMD,Yahoo,"Abiomed (ABMD) delivered earnings and revenue surprises of 3.77% and 3.60%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?",https://finnhub.io/api/news?id=0635a0ed67f95c575bd4630cf6f36a748f72fc4825ff6fceea55837e76d46ced
company,1628108100,"Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year",69505565,https://s.yimg.com/uu/api/res/1.2/7moBZjzjbjKmbqzd3_E27w--~B/aD0xNTQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5a716347284b8fd3eb415c237d10f214,ABMD,Yahoo,"DANVERS, Mass., August 04, 2021--Abiomed announces record revenue of $253 million, up 53% year over year.",https://finnhub.io/api/news?id=c79c5a3bbe1cbeeb1220028fc35f22c1f12c5d3ce9cf565e58b895f0e35052bd
company,1628099700,Abiomed: Fiscal Q1 Earnings Snapshot,69520945,,ABMD,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0b7b7b15341517f99649cadf4cefed8faf1fc469b0c150964cb9684b57926cc0
company,1628094780,"Abiomed Inc. stock rises Wednesday, outperforms market",69538990,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 1.43% to $331.20 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=c71dab5f0a2eee9c7bd2f12b3d41c8e2804e0334100c56ab1899d4166d38a980
company,1628093700,"Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year",69520946,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=0594f9a4625f0577ba179a63685f4cae09266f9d9ac91830f2336e5bd76d97ca
company,1628082121,"Medical Products' Aug 5 Earnings Roster: BDX, RMD & More",69491258,https://s.yimg.com/uu/api/res/1.2/k801.RUJ07Ee7atwPd.DSQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f54f709ae65e32f6086a21eeef8d44f3,ABMD,Yahoo,"Let's see how Medical Product companies' stocks like BDX, RMD, CAH, ABMD and XRAY are poised ahead of their earnings releases.",https://finnhub.io/api/news?id=1c5b20df21f0f4a28695da3a07122330b78c4aceace410f6b862f9024bde3687
company,1628047200,"Abiomed raises FY22 revenue view to $1.03B-$1.05B, consensus $1.02B",69520947,,ABMD,Thefly.com,Previous view $990M-$1.03... ABMD,https://finnhub.io/api/news?id=b1ff589c06512738258180ecf8ee18d2b3cad4f4c9b785ed8120d7ac5df650aa
company,1628047140,"Abiomed reports Q1 adjusted EPS $1.10, consensus $1.05",69520948,,ABMD,Thefly.com,Reports Q1 revenue $252.6... ABMD,https://finnhub.io/api/news?id=c43c2ebdd6b84047f12284369a71d148c772ee40a321a6cf7fcff3cc8017c053
company,1628008380,Abiomed Inc. stock outperforms competitors despite losses on the day,69483319,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. sank 0.56% to $326.52 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=61a66d2c652cc913b93f9fa4acff93ff6374f9f842057be7520f744bfb1c4259
company,1627921980,Abiomed Inc. stock outperforms market on strong trading day,69483321,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.37% higher to $328.36 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=6760c9bef867370bdc4b254d6aa4d82d54d0f1bab475224e44c808dfc6d929d3
company,1627662780,Abiomed Inc. stock outperforms market on strong trading day,69430383,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.72% higher to $327.14 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=1838399834e746d4d39d500a748843d01c14c7a2af3794b19d0b371420075a78
company,1627585507,Abiomed (ABMD) Reports Next Week: Wall Street Expects Earnings Growth,69392512,https://s.yimg.com/uu/api/res/1.2/6Ex_CnpNXcMseRWMhPXBow--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94,ABMD,Yahoo,Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=013acfa446ac66e4b1715866ea9de418e8c94546c647443bde1971c69cd9b111
company,1627576744,Abiomed (ABMD) to Report Q1 Earnings: What's in the Cards?,69392514,https://s.yimg.com/uu/api/res/1.2/MvtQ60gwW9VRzEVLKZwY0g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1591c17b88969fea846b68decb5325ff,ABMD,Yahoo,Continued strength in Abiomed's (ABMD) Impella product line is expected to have driven up Q1 sales.,https://finnhub.io/api/news?id=bd86b1650ca9f55be0aebd36c089422a8a4a1c44e56b96f34167fdbdb40e83f3
company,1627576380,"Abiomed Inc. stock rises Thursday, still underperforms market",69430384,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.31% higher to $324.81 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=45e7f2878577d8e4d1b9bb3dab1706e8e219655ff513c579e9e5df47f69cd80b
company,1627489980,"Abiomed Inc. stock rises Wednesday, outperforms market",69430385,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.57% higher to $323.80 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=0944312160ab6a9318cd0bd5ef3bd5853c0fae35b4f238c1f97cfc1eb07a4930
company,1627403580,"Abiomed Inc. stock falls Tuesday, underperforms market",69360886,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slumped 0.94% to $321.96 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=454a127fb2ba11a2e66859cc6bde26e2a4cbb48ed439a7976df5bc3bab8455d7
company,1627317180,"Abiomed Inc. stock falls Monday, underperforms market",69360887,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 1.07% to $325.00 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=44842ef1ea80a2614c3911e35427e0f4f1da071110263371278ba29b67675fb2
company,1627057920,"Abiomed Inc. stock rises Friday, outperforms market",69311881,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 1.54% to $328.52 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=2802fe748d3a7d4eeb7996ce61811f4f71d4392df890ba8aaebc9a7fb8cb7b25
company,1626971580,Abiomed Inc. stock outperforms market on strong trading day,69281882,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.21% higher to $323.54 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=6bf83e9f598c9091b3a9b8a6e7870692445e26aa31c2f2cb1bb332b951d37d52
company,1626885180,Abiomed Inc. stock underperforms Wednesday when compared to competitors,69276346,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slumped 0.23% to $322.85 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=78ae360f5e3c5671cd5890e0de74036b1f845e2fc4a9380a50d97c2f2e7087e0
company,1626798780,Abiomed Inc. stock outperforms market on strong trading day,69276348,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 2.85% to $323.59 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=ecad58cbcd08c6ab06d2f3dde9b9a095163b53eaacf5401383fa309857cf90c3
company,1626768032,Analysts See 11% Upside For The Holdings of RSP,69221786,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1562209449,ABMD,Nasdaq,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel",https://finnhub.io/api/news?id=3fc7ea99708a45660e250f21c5b80f284f6654bbb23299e6c9b8769edfd78947
company,1626712380,Abiomed Inc. stock outperforms market despite losses on the day,69276349,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 1.06% to $314.62 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=6ac235b9d925125e4c9864e82df0f5fa65696f12ec5b1e4f397264ca32fb65bb
company,1626453180,Abiomed Inc. stock outperforms market on strong trading day,69276351,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 2.51% to $317.98 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=907da0ca2ee191b24e11bc93e5d185e26a9d8dea19a74e31f1b9977bcd30ab17
company,1626366780,"Abiomed Inc. stock falls Thursday, underperforms market",69276352,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slumped 0.68% to $310.19 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=51e462c530da423b8193d315cc310892d5d0687a61fa472cd890a274ce9e73ed
company,1626346800,Abiomed First Quarter Fiscal 2022 Earnings and Conference Call Notification,68761974,https://s.yimg.com/uu/api/res/1.2/QnmbxwUmddpbf1P6vd4YrQ--~B/aD0xNTQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0e26e2caaf0b140ff428c708fff91ab8,ABMD,Yahoo,"DANVERS, Mass., July 15, 2021--Abiomed to release financial results for the first quarter of the fiscal year 2022 on Thursday, August 5, 2021.",https://finnhub.io/api/news?id=b03b38d91c054cf0a8fdb9f021f8ab153bd7b3188bc78ec010266b4a972cf4bc
company,1626332400,Abiomed First Quarter Fiscal 2022 Earnings and Conference Call Notification,68901483,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=332e1c0bdebc8ad0a6bc2ad4482da3d9db3d77093b075a04d1142f48ae79f6e6
company,1626326058,I Built A List Of Growing Companies And Abiomed (NASDAQ:ABMD) Made The Cut,68761975,https://s.yimg.com/uu/api/res/1.2/8.7wAmlAutGU5iXFvarF9A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/542f5a72d5758cc977dad831c5295870,ABMD,Yahoo,"Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...",https://finnhub.io/api/news?id=11b7c764a8b1934282b3e0f3f7e2a3ec5cb98406aec3aad42c496c3392a2bd03
company,1626280380,"Abiomed Inc. stock falls Wednesday, underperforms market",68728186,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 2.14% to $312.30 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=33ba64e5a21f4c453adee4f413bb561d6db6e65c40640a219a2851033b0c6ba2
company,1626193980,Abiomed Inc. stock outperforms competitors despite losses on the day,68728187,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 0.93% to $319.13 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=5d0d892d1e6fea93523aab66f5315bf2fc9a0f1aa69091f34ce9c84c7df7cc5f
company,1626182560,"Here is What Hedge Funds Think About ABIOMED, Inc. (ABMD)",68703876,https://s.yimg.com/uu/api/res/1.2/.fdmm5dayQmSaEz0p4b60Q--~B/aD0yMDQ4O3c9MTYxMzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/f99d4629e8eba313b33ba9bdf3fd4a7e,ABMD,Yahoo,"Is ABIOMED, Inc. (NASDAQ:ABMD) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. […]",https://finnhub.io/api/news?id=af8dc9728a21cd78132dd1c54cc84cd32290e4c75fdfcefd12e4435405c25116
company,1626171788,Abiomed: Recovery Mode Has Been Activated - Reiterate Buy Rating,68704277,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1262218043/medium_image_1262218043.jpg,ABMD,SeekingAlpha,"Abiomed has commenced its path to recovery on the charts, following a big hit in April this year. Find out more about the outlook here.",https://finnhub.io/api/news?id=6fcfed5eae16e1d867406f9678dfd2d20acf0c87a72cd8ef3883bc00d5c2eff9
company,1626107520,"Abiomed Inc. stock falls Monday, underperforms market",68728188,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. sank 0.81% to $322.14 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=2fb96649fd0b1ef258ac8b8825aa93caef7ec7c526380bb341d5b73c684546be
company,1626103810,"Noteworthy Monday Option Activity: COF, ABMD, HYFM",69071415,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?2047652197,ABMD,Nasdaq,"Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Capital One Financial Corp (Symbol: COF), where a total of 15,419 contracts have traded so far, representing approximately 1.5 million underlying shares.  That amounts t",https://finnhub.io/api/news?id=3c87a3f58ed1f900497e0e4c9f105e0b97c42a9a29590ad5420903cc0f814188
company,1625848320,"Abiomed Inc. stock falls Friday, underperforms market",68728189,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. sank 0.08% to $324.77 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=c619f839b68cd8ac2d9536030f9a991279eb561077ad67cfead046fdb61c982b
company,1625761980,"Abiomed Inc. stock falls Thursday, underperforms market",68662672,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 2.84% to $325.04 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=7641cfc139f2db4746f2464bb6cc1ad2719bb25924251e7a2e58f6e35c567fb8
company,1625675580,Abiomed Inc. stock outperforms competitors on strong trading day,68662673,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 2.39% to $334.53 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=0573158413460751ba931a8a06a14bf5d3a959e62c61373ff76d02e25d267edb
company,1625589180,"Abiomed Inc. stock rises Tuesday, outperforms market",68662674,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 3.06% to $326.71 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=68b8eb55b9647601a7b49248c44d4512d6c5614ae6df4c3f4e07b260a40857ec
company,1625543820,U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.60% By Investing.com,68735105,https://i-invdn-com.investing.com/news/LYNXMPED1J0AC_L.jpg,ABMD,Investing.com,U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.60%,https://finnhub.io/api/news?id=16a8674ac28c0079521721dd936e554ba00f08c496724aaeebb6cbf06b4e403b
company,1625447378,"Is Now The Time To Look At Buying Abiomed, Inc. (NASDAQ:ABMD)?",68646295,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?150175965,ABMD,Nasdaq,"Let's talk about the popular Abiomed, Inc. (NASDAQ:ABMD). The company's shares    received a lot of attention from a substantial price increase on the NASDAQGS over the last few months.    With many analysts covering the large-cap stock, we may expect any price-sensitive announc",https://finnhub.io/api/news?id=6f5a18a916722e9520536e9317dc0aac5b506f4d6a0000dd7c52b0d31a308cbc
company,1625310420,Could This Recently IPOed Medical Device Maker Make You Rich?,68588691,https://s.yimg.com/uu/api/res/1.2/tOKCH5Yzxym8xx_BXLrMQw--~B/aD0xMTMwO3c9MTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/f14fd143693b9bcba7d258de47ec2b4d,ABMD,Yahoo,"NeuroPace (NASDAQ: NPCE), is growing the implantable device market for treating drug-resistant focal epilepsy and setting itself up to dominate it for years to come.  With an offering that provides better outcomes than its competition, significant penetration into epilepsy centers across the U.S., and potential label expansions that could just about double its current addressable market, this company could offer significant upside to investors.  NeuroPace makes a $50,000 implantable device, the RNS (Responsive Neurostimulation) System, that continuously monitors epilepsy patients' brain activity and responds to patient-specific seizure patterns.",https://finnhub.io/api/news?id=ca37e4bae0b698905acad225b0357931557fdb8a698b7ee6131b6ebd9f0f7697
company,1625296020,Could This Recently IPOed Medical Device Maker Make You Rich?,68646296,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?2047899949,ABMD,Nasdaq,"NeuroPace (NASDAQ: NPCE), is growing the implantable device market for treating drug-resistant focal epilepsy and setting itself up to dominate it for years to come. With an offering that provides better outcomes than its competition, significant penetration into epilepsy centers",https://finnhub.io/api/news?id=bd4b3115c164b87668763895ae7e723582a45f72c9a9517d6947914e6be07e03
company,1625243580,Abiomed Inc. stock outperforms competitors on strong trading day,68662675,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 1.31% to $317.02 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=38e7f37951421c1f5be694369bafd79f9ae1a0a96d0d296ff3a9da7174457aa1
company,1625157180,"Abiomed Inc. stock rises Thursday, still underperforms market",68571434,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.26% higher to $312.91 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=69e75827e968c9ed0d2fa8c61892075b808c4752f3446c0b640b7e5aa274f10f
company,1625070780,Abiomed Inc. stock outperforms competitors despite losses on the day,68571435,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 0.37% to $312.11 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=88d1a56e3b208d905b05dd0073593c49f4198acc06c833f5293b0ba5699a2f46
company,1625058361,Abiomed's (ABMD) Impella RP With SmartAssist Gets FDA Nod,68536674,https://s.yimg.com/uu/api/res/1.2/5Q_hUjtCGiFNkT7hRMCFWw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4e34facdd1fb2dc7d4782bd97cabacb5,ABMD,Yahoo,Abiomed's (ABMD) Impella RP with SmartAssist gets the highest level of approval from the FDA for treatment of right heart failure.,https://finnhub.io/api/news?id=d966cad054811f7cf65e08a68b61a7ee993f9543d62a06825ed401705a3d7fa8
company,1625054001,"Noteworthy ETF Outflows: RSP, GNRC, RMD, ABMD",68646297,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1636537797,ABMD,Nasdaq,"Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500— Equal Weight ETF (Symbol: RSP) where we have detected an approximate $992.6 million dollar outflow -- that's a 3.4% decre",https://finnhub.io/api/news?id=f0fc2cd5b3dd6a9d48ce7b71da8b54f78774a5a68c7988281d32b29025e5a3be
company,1624984380,Abiomed Inc. stock outperforms competitors on strong trading day,68571436,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.27% higher to $313.27 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=6ae4dd748d006d8a3a3f2617d463c48d204d7f1fdf97cc0dd7c1c41dce208ed0
company,1624968180,FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure,68526991,https://s.yimg.com/uu/api/res/1.2/R1_dw4nRFq_Gpx6MdRu28g--~B/aD00ODA7dz0zMzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/97fbc2235fda78071579a22c0d57d988,ABMD,Yahoo,"DANVERS, Mass., June 29, 2021--Abiomed’s (NASDAQ: ABMD) newest right heart pump, the Impella RP with SmartAssist, has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) as safe and effective to treat acute right heart failure for up to 14 days.",https://finnhub.io/api/news?id=d298146c4e9a0947b3ac609084b6a8c6cf11158879848a470c7ae0b5c6695c05
company,1624950240,Abiomed announces Impella RP with SmartAssist receives FDA pre-market approval,68735106,,ABMD,Thefly.com,Abiomed announces Impella RP with SmartAssist receives FDA pre-market approval ABMD,https://finnhub.io/api/news?id=75a1a0c9b5c0535e167ce5fdbf8dca474d2f5f394f2e797100e362a7a6ecafb5
company,1624897920,Abiomed Inc. stock outperforms market on strong trading day,68571437,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.29% higher to $312.44 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=5c327234dae734691f442b15d97b01fd46bf2117d8c6834b92481ac5040eaac5
company,1624567733,10 Medical Device Stocks for 2021,68473233,https://s.yimg.com/uu/api/res/1.2/zYUSulj.G3A0gz_auaM4ow--~B/aD01MDA7dz03NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/82a4af94e90942ec120dbb80f48cb463,ABMD,Yahoo,"In this article, we will take a look at some of the best medical device stocks for 2021. To skip our detailed analysis on the medical device industry, the impact of the COVID-19 pandemic on the industry, and its future outlook, click to see the 5 Medical Device Stocks for 2021. The COVID-19 pandemic certainly […]",https://finnhub.io/api/news?id=1606fce214d860868187e4daf1342f59cac0605218cc2e180efced6137e3c141
company,1624545151,"Thursday Sector Laggards: Utilities, Healthcare",68473729,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1770573398,ABMD,Nasdaq,"In afternoon trading on Thursday, Utilities stocks are the worst performing sector, not showing much of a gain.  Within the sector, American Water Works Co, Inc. (Symbol: AWK) and CenterPoint Energy, Inc (Symbol: CNP) are two of the day's laggards, showing a loss of 1.2% and 0.",https://finnhub.io/api/news?id=9c08bd1b54ffd892322613cfcf43947ee28bd9b4258a892e89804114b542bce7
company,1624506960,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.95% By Investing.com,68470307,https://i-invdn-com.investing.com/news/LYNXNPEB8R0JA_L.jpg,ABMD,Investing.com,U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.95%,https://finnhub.io/api/news?id=b02c93ac5d77ae8549ecfe583c4fb5e9965c3a0ea567c3e57c9be9e1e7b568e6
company,1624500960,"Abiomed Inc (ABMD) Chairman, President, CEO Michael R Minogue Sold $8.1 million of Shares",68470758,,ABMD,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=952fedfda80cc7220e2df1938229166b0778ebbeb6c87d8bd3121056dbee645f
company,1624459978,"Wednesday Sector Laggards: Utilities, Healthcare",68473507,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?231164975,ABMD,Nasdaq,"Looking at the sectors faring worst as of midday Wednesday, shares of Utilities companies are underperforming other sectors, showing a 0.8% loss.  Within that group, American Water Works Co, Inc. (Symbol: AWK) and Entergy Corp (Symbol: ETR) are two of the day's laggards, showin",https://finnhub.io/api/news?id=f3620d563df64f48966df107db661760214f9a5d5018fa29b04a99d63e0e576f
company,1624379580,Abiomed Inc. stock outperforms competitors on strong trading day,68433466,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.65% higher to $327.19 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=53221ef304cf6a78d4d85c5891a1f28c86abd16de4fa5b703849f15ac4eb14c0
company,1624364952,Abiomed (ABMD) Enters Overbought Territory,68430181,https://s.yimg.com/uu/api/res/1.2/_LT6pKD_Fk90UGSt.TnE5Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e10425bef32c421f16ccc0d2a8c8bb61,ABMD,Yahoo,"Abiomed (ABMD) has moved higher as of late, but there could definitely be trouble on the horizon for this company",https://finnhub.io/api/news?id=c77a3037ed34a3a84cf15c4ead704f57ab38feea787ec9d1fbc79ec8219a8233
company,1624293180,Abiomed Inc. stock outperforms competitors on strong trading day,68433467,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 2.05% to $325.09 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=aa2f64a4fefce6dbfa9fbdba7545267daead4b881e30ee8ad42025c2a09d8644
company,1624033980,Abiomed Inc. stock outperforms market on strong trading day,68433468,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 1.91% to $318.57 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=1192dc5e52ee4407b070cd927774781867ab3049f17df8fb6d5dae5ec520210e
company,1624023623,"Noteworthy Friday Option Activity: ABMD, UNP, CCL",68371362,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1853165106,ABMD,Nasdaq,"Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in ABIOMED, Inc. (Symbol: ABMD), where a total of 1,296 contracts have traded so far, representing approximately 129,600 underlying shares.  That amounts to about 49.5% of A",https://finnhub.io/api/news?id=24ad7df17873afdb8c18530d26c66ad49c90adcf38c333efd13f3bf653862f68
company,1624019940,"Noteworthy Friday Option Activity: ABMD, UNP, CCL",68355974,,ABMD,Stock Options Channel,"Staff article entitled Noteworthy Friday Option Activity: ABMD, UNP, CCL, about stock options, from Stock Options Channel.",https://finnhub.io/api/news?id=4fdecca261da15c2b2f364bd038b19396735d9576150fa37459757faf3ba5947
company,1624006560,Early notable gainers among liquid option names on June 18th,68349229,,ABMD,Thefly.com,Early notable gainers among liquid option names on June 18th NVDA ADBE LEN ABMD OXY,https://finnhub.io/api/news?id=a0ceeb938bf465a54261bf45583982fc2430eb7ddfd3d363737ecd54f085cec9
company,1624004460,"Friday’s Top Analyst Upgrades and Downgrades: Alaska Air, Biogen, Cirrus Logic, Lennar, Match, Occidental and United Airlines",68349428,https://247wallst.com/wp-content/uploads/2020/04/imageForEntry2-Rv3.jpg,ABMD,247WallSt,"Friday’s top analyst upgrades and downgrades included Biogen, Cirrus Logic, Delta Air Lines, Lennar, Match, Occidental Petroleum, Tupperware and United Airlines.",https://finnhub.io/api/news?id=27d649ce2c4fb53d27049832f28a8f7aa946fdf034040b5a3dc296b88c8dc07b
company,1623995280,Abiomed initiated with a Buy at Deutsche Bank,68351479,,ABMD,Thefly.com,Abiomed initiated with a Buy at Deutsche Bank Deutsche Bank ABMD,https://finnhub.io/api/news?id=b87a05465039aae26c1b3ed009a1e462344437b504784b78468e61df41b3f9df
company,1623988920,"Abiomed confident in near-term business recovery, says Piper Sandler",68351480,,ABMD,Thefly.com,"Abiomed confident in near-term business recovery, says Piper Sandler Piper Sandler ABMD",https://finnhub.io/api/news?id=48c98ed31c4afcd577e46ae24ddcee6100dc1069fbbfec0f9e5c2d9828865e14
company,1623988560,U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.58% By Investing.com,68361440,https://i-invdn-com.investing.com/news/a3d12ec27fa0e3457d56abfdb5654300_L.jpg,ABMD,Investing.com,U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.58%,https://finnhub.io/api/news?id=85a6a229469e47dfec7f092f5e16bcfaff3f887c25029a4e742f9cd0e139a71d
company,1623947580,Abiomed Inc. stock outperforms competitors on strong trading day,68348467,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 3.07% to $312.61 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=982cca3c3395b786da80d3dd8c4b839d4b38e1f80db9131c90f452ba398bec3b
company,1623861180,Abiomed Inc. stock outperforms market on strong trading day,68348468,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.52% higher to $303.30 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=2dbe75b584cd160f29ccd7118429278f7ad1b05f94acea49683bb127e931f1ec
company,1623774780,Abiomed Inc. stock underperforms Tuesday when compared to competitors,68348469,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. dropped 0.38% to $301.72 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=936467b635e09d5acc337a791620214d90e22a67bea26d56d30b790fba387991
company,1623741180,Abiomed management to meet virtually with Piper Sandler,68283539,,ABMD,Thefly.com,Abiomed management to meet virtually with Piper Sandler ABMD,https://finnhub.io/api/news?id=6aa2d20faec8a0c78f9512c333ce49d9b2e07e418bf9ad3d038a8359ab7baf90
company,1623734091,"What Does Abiomed, Inc.'s (NASDAQ:ABMD) Share Price Indicate?",68281098,https://s.yimg.com/uu/api/res/1.2/8.7wAmlAutGU5iXFvarF9A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/542f5a72d5758cc977dad831c5295870,ABMD,Yahoo,"Abiomed, Inc. ( NASDAQ:ABMD ) saw a decent share price growth in the teens level on the NASDAQGS over the last few...",https://finnhub.io/api/news?id=aef9706a3f0e4f9e7b8d34c68b8110c0990b86532d7e7fa3e58006a57bdddd1c
company,1623688380,Abiomed Inc. stock outperforms competitors on strong trading day,68348470,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 1.23% to $302.87 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=eca5c1e548a193351b84b29f19f8f595199e3c90525c65fadf115df00ceddbf5
company,1623658040,The Math Shows FXH Can Go To $129,68372048,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1048961592,ABMD,Nasdaq,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel",https://finnhub.io/api/news?id=49b9b95e691166ec81369695b4bca47a8a14fe85be94200b1d85c2ce726b3f7f
company,1623256380,Abiomed Inc. stock outperforms market on strong trading day,68138093,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 1.61% to $293.82 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=d9a34e91462597cd91568aead6a1d0277ab0b4902bf3fdec89307cf61ab7cdb0
company,1623169920,Abiomed Inc. stock underperforms Tuesday when compared to competitors,68138097,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. dropped 0.68% to $289.17 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=2cb5febde9fee2f25b6a72ade41ec455a22e21b692c0e13bff29daf3b323ecbb
company,1623165929,"Tuesday Sector Laggards: Utilities, Healthcare",68355197,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1315584564,ABMD,Nasdaq,"The worst performing sector as of midday Tuesday is the Utilities sector, showing a 0.7% loss.  Within that group, CMS Energy Corp (Symbol: CMS) and American Electric Power Co Inc (Symbol: AEP) are two of the day's laggards, showing a loss of 4.5% and 2.5%, respectively.  Among",https://finnhub.io/api/news?id=d116ce87efd31e17b2dec6449bf557367bb82a80d815807a47097dae82b2b802
company,1623152940,"Tweet suggests Abiomed study trending in right direction, says Piper Sandler",68072016,,ABMD,Thefly.com,"Tweet suggests Abiomed study trending in right direction, says Piper Sandler Piper Sandler ABMD",https://finnhub.io/api/news?id=d6b83dfe8b9740d9c3ab4ba5f5529f30b4de125f420664fa2f2a4e1a77d869ab
company,1623083580,Abiomed Inc. stock outperforms market on strong trading day,68138099,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.57% higher to $291.15 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=1173275c4ed2a2d718f6fd06d2d18c9742b42362f919f315fcad1be6cb0c911c
company,1622862782,Returns On Capital At Abiomed (NASDAQ:ABMD) Have Hit The Brakes,68372050,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1741535651,ABMD,Nasdaq,"If we want to find a potential multi-bagger, often there are underlying trends that can provide clues.  One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed.  Put si",https://finnhub.io/api/news?id=4b55ec14b37ccf48b519f95f677aa38f5a5c9a28b791db4b692ca20a45c8caef
company,1622731202,Abiomed's (ABMD) preCARDIA Buyout Expands Its Product Portfolio,68089121,https://s.yimg.com/uu/api/res/1.2/Bwjibxk8IIsM7dLPsV1mcQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08380da297340a988e9902fee4e753cb,ABMD,Yahoo,Abiomed's (ABMD) latest acquisition is expected to improve patient outcome as well as lower the cost of care.,https://finnhub.io/api/news?id=a57a3b04c6577844f80f8aa5c6ea0f2079e92e0b49a178515b06193be51f0e3d
company,1622577300,Harding Loevner Global Small Companies Equity Q1 2021 Letter,67961608,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,ABMD,SeekingAlpha,Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family.,https://finnhub.io/api/news?id=79ef746ad5ba7fd5b820aa809412353e057b27f40f26027dca91017672f4e2c0
company,1622548980,"Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients",68089123,https://s.yimg.com/uu/api/res/1.2/uqCWcg7nJiL22ozfTt4NKg--~B/aD04MTt3PTE0NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/e5557a8131c08f3bc71ff9aba3b5cfcc,ABMD,Yahoo,"Abiomed (NASDAQ: ABMD) has acquired preCARDIA, developer of a proprietary catheter and controller that will complement Abiomed’s product portfolio to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA system is uniquely designed to rapidly treat ADHF-related volume overload by effectively reducing cardiac filling pressures and promoting decongestion to improve overall cardiac and renal function.",https://finnhub.io/api/news?id=0f6de5b76d73802030dab85e3e8f933bec3dc41643c3ff56b91a40baced687bf
company,1622538960,William Blair to hold a virtual conference,67964393,,ABMD,Thefly.com,William Blair to hold a virtual conference ABMD ADPT CERT EXAS MAX PRLB TDOC ZEN WISH TCMD PLMR EVER KRNT PETQ SIEN SDC VRSK EFX DXCM AXON GH,https://finnhub.io/api/news?id=9fb3bd6809f4cb7509bdda6cf690c389980ed2ed5aef50ce0be241588fed61b2
company,1622538571,Abiomed Acquires Medical Device Company PreCARDIA,69101600,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?17269439,ABMD,Nasdaq,"(RTTNews) - Abiomed (ABMD) said it has acquired preCARDIA, developer of a proprietary catheter and controller that will complement Abiomed's product portfolio to expand options for patients with acute decompensated heart failure or ADHF.",https://finnhub.io/api/news?id=f0d32d2483165ed068268ba056933921e9f9a5b4cff516f438b99041263148bb
company,1622534580,"Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients",68735118,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=de767ee50b8ef508c3db602ef3305ec579490f03bcaecd098e9ae70ff09bfbc7
company,1622532060,"Abiomed acquires preCARDIA, a medical device company",68735119,,ABMD,Thefly.com,"Abiomed acquires preCARDIA, a medical device company ABMD",https://finnhub.io/api/news?id=d234a475bf18936b40e9454279411fc20c5caf558c72a79c02ee7bf0a7d4bc00
company,1622083598,Here's Why Abiomed Stock Is Attractive After A 20% Drop,67930811,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?561312214,ABMD,Nasdaq,"The stock price of Abiomed (NASDAQ:ABMD), a medical devices company best known for Impella, the world’s smallest heart pump, looks attractive at current levels of $280, despite it being up 2x from the levels of $132 it was at on March 23, 2020, when broader markets made a",https://finnhub.io/api/news?id=09e183a502616a36d983a9d9dd3c69f22996f3bc290968652b006e46d7a8a766
company,1621940400,Abiomed to Present at Upcoming Investor Conferences,68089125,https://s.yimg.com/uu/api/res/1.2/UE23xCgH.x6OdzvKkpCWWA--~B/aD0xNTQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/cc815f714499a1a7aefc6e6464abc68e,ABMD,Yahoo,Abiomed to present at William Blair’s 41st Annual Growth Stock Conference and the Jefferies Virtual Healthcare Conference.,https://finnhub.io/api/news?id=0bd5195a61448b949003a2abdd9174a885c02867611834c705522251e4b08a0e
company,1621937520,"Sands Capital Cuts Adobe, Amazon",67919951,,ABMD,GuruFocus,GuruFocus Article or News written by Tiziano Frateschi and the topic is about: Firm's largest sales of the 1st quarter,https://finnhub.io/api/news?id=35a0ac8bc816742ebdf162b70efb740c4bc66acb4885fb9a334a5033a238c8d5
company,1621926000,Abiomed to Present at Upcoming Investor Conferences,67919952,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=128acc855006566abbd055c697ea4130ad657536b660d402d1e7cb6a9dd909bb
company,1621148952,Shareholders Are Thrilled That The Abiomed (NASDAQ:ABMD) Share Price Increased 176%,67867819,,ABMD,Yahoo,"It might be of some concern to shareholders to see the Abiomed, Inc. ( NASDAQ:ABMD ) share price down 20% in the last...",https://finnhub.io/api/news?id=ddcc59113eb1de8dc8bfbbd2d6faa20c79a4b20485234d7875a3c9d9d93b4409
company,1621009980,"Abiomed Inc. stock rises Friday, outperforms market",67852113,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 2.23% to $268.56 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=0f783320a5007172bf3111f846bd475176573d7c1c21981f55098c56c03419e0
company,1620923580,"Abiomed Inc. stock falls Thursday, underperforms market",67852114,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 3.50% to $262.71 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=4c56a9299a94484e8f9ccbce19c7aabc2827873e0dc45c04fc4646d05e667cb6
company,1620886380,Abiomed Stock Is Believed To Be Modestly Undervalued,67820129,,ABMD,GuruFocus,GuruFocus Article or News written by GF Value and the topic is about: ,https://finnhub.io/api/news?id=aa71c06a82fbd02bf611f3a2122b0c4aaaf22b7e1bd07d9cc7fa5acda0bd282b
company,1620873540,"William Blair Investment Management, Llc Buys Charles River Laboratories International Inc, ...",67808355,,ABMD,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=546ea5546cff221d025d8bd022e04b46e7a85343b948b6ddd4c0066a8cae4138
company,1620837180,Abiomed Inc. stock underperforms Wednesday when compared to competitors,67805300,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 2.87% to $272.25 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=7ee152bdc1e8f61e26e991e3c81c8d4128a88a7b1ba599c746f80948315c91cd
company,1620820754,Relative Strength Alert For ABIOMED,67780719,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1733389833,ABMD,Nasdaq,"Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.  One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which m",https://finnhub.io/api/news?id=969b6ba61dbc20b44474bb1f1e8ee105cbf452a79e09098c0c4598afb91868f5
company,1620750780,Abiomed Inc. stock outperforms market despite losses on the day,67805301,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. dropped 0.86% to $280.30 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=ea243d0636c325f5ff9f027ebf1a444ed34c488c9f980b1f815d897300ad2530
company,1620729600,Avoid the Dogecoin Crash by Buying These 2 Growth Stocks Instead,67744100,,ABMD,Yahoo,"Dogecoin may be breaking its all-time highs every other day, but there's nothing averting a catastrophic fall.",https://finnhub.io/api/news?id=0e199e31a5077e9d91381db31aaffdd1c01c5df67290fdafe7a35c52f06dcc3f
company,1620718487,Look Under The Hood: QQQJ Has 18% Upside,67740489,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1357963389,ABMD,Nasdaq,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel",https://finnhub.io/api/news?id=483e8bed83791581a304670b3dbc06254a462574cacfc9bce54f1971220576f9
company,1620715200,Avoid the Dogecoin Crash by Buying These 2 Growth Stocks Instead,67738224,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?410538303,ABMD,Nasdaq,"If you want to send someone on a wild goose chase, send them to find a serious investor who's willing to state on the record that Dogecoin (CRYPTO: DOGE) is a surefire long-term investment. Dogecoin may be fun to buy, but it's unlikely be popular forever, and there's next to zero",https://finnhub.io/api/news?id=bf248652856a5d1903f188aeee3567fe3c5605061327b637e98b1b141199dde0
company,1620664380,Abiomed Inc. stock underperforms Monday when compared to competitors,67805303,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 4.75% to $282.72 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=7858c9ec0ec67f54f75a2362d101a4b2a57e3ba02e01b078b9f6e7965a13ca04
company,1620657215,"Monday Sector Laggards: Technology & Communications, Healthcare",67718772,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1514938217,ABMD,Nasdaq,"The worst performing sector as of midday Monday is the Technology & Communications sector, showing a 1.3% loss.  Within the sector, Qorvo Inc (Symbol: QRVO) and Monolithic Power Systems Inc (Symbol: MPWR) are two of the day's laggards, showing a loss of 6.8% and 5.9%, respe",https://finnhub.io/api/news?id=74850d4ae644cdbd7989660e24bee0667fe9e412c2e1e3c6b19223e8f6d14ae1
company,1620405180,"Abiomed Inc. stock rises Friday, still underperforms market",67692925,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.37% higher to $296.81 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=d25828ae0da185dba16bbd9f2b3c06f57336447dfc981021544d78e250b1c9b6
company,1620318780,"Abiomed Inc. stock falls Thursday, underperforms market",67692926,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 1.69% to $295.72 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=0ca216b8b36a3c52aa1c4d32e289e6b563b7372a74f1e723a1b057627e11a452
company,1620293940,"Abiomed could face new competition from Boston Scientific, says Raymond James",67626840,,ABMD,Thefly.com,"Abiomed could face new competition from Boston Scientific, says Raymond James Raymond James BSX ABMD",https://finnhub.io/api/news?id=d5edecf4dbfc2e21323a67d0f862e3cdcdc6d4928548021d88e3d098caa978be
company,1620232380,Abiomed Inc. stock underperforms Wednesday when compared to competitors,67692927,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 1.38% to $300.79 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=da64bc058466e708421c311dbd2cb21f97d4c27637426c59b26e028e0c03956a
company,1620213859,ABMD Crosses Below Key Moving Average Level,67606104,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?953625636,ABMD,Nasdaq,"In trading on Wednesday, shares of ABIOMED, Inc. (Symbol: ABMD) crossed below their 200 day moving average of $300.26, changing hands as low as $299.76 per share.  ABIOMED, Inc. shares are currently trading down about 1.1% on the day.  The chart below shows the one year perform",https://finnhub.io/api/news?id=3b699627695a74160cb3996a3edce73e0b904a8ff6b0aed2114146c40476d03c
company,1620210240,ABMD Crosses Below Key Moving Average Level,67591466,,ABMD,Market News Video,"In trading on Wednesday, shares of ABIOMED, Inc - (ABMD) crossed below their 200 day moving average of $300.26, changing hands as low as $299.76 per share. - ABMD.",https://finnhub.io/api/news?id=273b99c34f657adc2ce3d70d47f1aadf0d439aa258f608186f433b59f8466b48
company,1620145980,"Abiomed Inc. stock falls Tuesday, underperforms market",67498823,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 1.18% to $305.00 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=8b6a0b4ced32137c035437cc853308ef85cb5d2f15b58b6f1106f59198c5cbbd
company,1620134161,New Strong Sell Stocks for May 4th,67452742,https://s.yimg.com/uu/api/res/1.2/kr_HT6.35NDiR7sMr0eS1g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4d1fa526b488a2eff982103dbea1e25d,ABMD,Yahoo,"ABMD, CLMT, FLMN, GRUB, and IHG have been added to the Zacks Rank #5 (Strong Sell) List on May 4, 2021",https://finnhub.io/api/news?id=63b78eb753ec8af7bd19f3b744665141c6cb40fbf8f19a246fb71560ef61bec5
company,1620128700,"Abiomed to Shareholders: Patience Please, Growth Is On The Way.",67446744,,ABMD,Yahoo,"Despite record revenue for its latest quarter, the medical device maker's shares sank 8% following its earnings release. But its next stage of growth is coming.",https://finnhub.io/api/news?id=abb75aca2c384d7deef79fc12e0a65441fe0093617fae09fcee3f34b3f2336a8
company,1620123300,The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts,67441725,,ABMD,Yahoo,"It's no secret that in-person medical appointments are hard to come by in the age of COVID-19. But now that the U.S. appears to be getting the pandemic under control, people are eagerly flocking back to the clinic for everything they've put off, from dental cleanings to heart surgery.",https://finnhub.io/api/news?id=3cdbcea79e903c2e5ab779f1ee01413caaca0781813716a131cd327a3d1badfd
company,1620114300,"Abiomed to Shareholders: Patience Please, Growth Is On The Way.",67446338,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?602527034,ABMD,Nasdaq,"Abiomed (NASDAQ: ABMD) reported its fiscal 2021 fourth-quarter earnings last week, with 17% year-over-year revenue growth of $243 million for the quarter. For many mature medical device companies, this would be a fantastic result. Unfortunately, for the full fiscal year, revenue",https://finnhub.io/api/news?id=a97d882cad2908b5a39c87bfcaa15ecaec4b049d2d75beb649ea09b37167304b
company,1620108900,The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts,67442526,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1067594483,ABMD,Nasdaq,"It's no secret that in-person medical appointments are hard to come by in the age of COVID-19. But now that the U.S. appears to be getting the pandemic under control, people are eagerly flocking back to the clinic for everything they've put off, from dental cleanings to heart sur",https://finnhub.io/api/news?id=df0ccb2b300301d8f074765f0b2841857f7b1bce122f313784cc371723555267
company,1620059580,"Abiomed Inc. stock falls Monday, underperforms market",67498826,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 3.77% to $308.64 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=561fbbe1de04f630664bc145ae8b871e52726f05c5e064d9f6ad1117b584b0a3
company,1620014220,U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.70% By Investing.com,67377924,https://i-invdn-com.akamaized.net/news/LYNXMPEB4I0NH_L.jpg,ABMD,Investing.com,U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.70%,https://finnhub.io/api/news?id=48723d797b07efff31df6a963e8af80c5be8cd8e09dc82d7ef9cbf1f03d497e0
company,1619800380,Abiomed Inc. stock outperforms competitors despite losses on the day,67193860,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. sank 0.68% to $320.73 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=4f01b57701f7e75e75ab530d79d088f17633efd01207cfe279145e2efeee0ca8
company,1619784240,"The Eaton Vance Fund sells Novartis, Pfizer",67161585,,ABMD,GuruFocus,GuruFocus Article or News written by Tiziano Frateschi and the topic is about: Firm's largest sales of the 1st quarter,https://finnhub.io/api/news?id=f79fc81125a070f42e5db67d78bba31bb97592a36b768d6754466b34618b58a2
company,1619780400,Validea Peter Lynch Strategy Daily Upgrade Report - 4/30/2021,67144816,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?2061510639,ABMD,Nasdaq,"The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.ABIOMED, INC. (ABMD) is a la",https://finnhub.io/api/news?id=9fc7297a72bf15df4812fa7a51fa90b99fb17030ce33e2fc6a3a98a5870fa198
company,1619718185,ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q4,67133241,https://s.yimg.com/uu/api/res/1.2/Bwjibxk8IIsM7dLPsV1mcQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/08380da297340a988e9902fee4e753cb,ABMD,Yahoo,ABIOMED's (ABMD) international and U.S. Impella revenues improve in Q4.,https://finnhub.io/api/news?id=6126dd8b1df043d1c32f9b71858452421630ac42241cb1c1b04e8e3913c1b7a9
company,1619717456,Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript,67133242,https://s.yimg.com/uu/api/res/1.2/zmj.74VZmDKFyMQXCAbujg--~B/aD0xNDk0O3c9MTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73,ABMD,Yahoo,"ABMD earnings call for the period ending March 31, 2021.",https://finnhub.io/api/news?id=a0ff8a10e59b0b47cf6570252a169bdb37a1b859c3f372c7700c0ffc4ad24108
company,1619713980,Abiomed Inc. stock underperforms Thursday when compared to competitors,67135000,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 8.04% to $322.94 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=8e11040b1230f3536964a77010174e4e686b56a3e3f783e4da2dca65213672ff
company,1619706755,"Thursday Sector Laggards: Healthcare, Technology & Communications",67122571,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?235033591,ABMD,Nasdaq,"The worst performing sector as of midday Thursday is the Healthcare sector, showing a 0.8% loss.  Within the sector, ABIOMED, Inc. (Symbol: ABMD) and Hologic Inc (Symbol: HOLX) are two large stocks that are lagging, showing a loss of 8.0% and 7.8%, respectively.  Among healthca",https://finnhub.io/api/news?id=b301416ecd85f7c97b7d0860e3f10285d8e698dffc8999dc588e431ddbf109ab
company,1619705440,Abiomed's (ABMD) CEO Mike Minogue on Q4 2021 Results - Earnings Call Transcript,67117855,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,ABMD,SeekingAlpha,"Abiomed, Inc. (NASDAQ:ABMD) Q4 2021 Earnings Conference Call April 29, 2021 8:00 AM ET Company Participants Todd Trapp – Vice President and Chief Financial Officer Mike Minogue – Chairman,...",https://finnhub.io/api/news?id=e96c35ec2b24185a48264e1692f1b48e777a8a83d903fcbdc6c2d73fdd715419
company,1619703056,Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript,67124926,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1453792229,ABMD,Nasdaq,Image source: The Motley Fool.,https://finnhub.io/api/news?id=f7c6bd27e1d43c4b3cb054c833affa7b4c1b5e2c4acf447380669bc454217635
company,1619700312,Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates,67112228,https://s.yimg.com/uu/api/res/1.2/9naTdeJlVMX28sdlDpLdrQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4,ABMD,Yahoo,"Abiomed (ABMD) delivered earnings and revenue surprises of 12.73% and 4.72%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?",https://finnhub.io/api/news?id=ca541f9e8525bcff891cc34b9d6706052441ee19b7b905428679d1195dd25d45
company,1619699940,"Abiomed earnings selloff a buying opportunity, says Piper Sandler",67118609,,ABMD,Thefly.com,"Abiomed earnings selloff a buying opportunity, says Piper Sandler Piper Sandler ABMD",https://finnhub.io/api/news?id=96724dace516f3019918168c191358e0a139fb8e5a7f21b2c1439ef6e7ba0920
company,1619694614,"Abiomed, Inc. 2021 Q4 - Results - Earnings Call Presentation",67113598,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,ABMD,SeekingAlpha,"The following slide deck was published by Abiomed, Inc. in conjunction with their 2021 Q4 earnings call.",https://finnhub.io/api/news?id=0c88265cfec326e57781032b3c4f4df01ec22743dc3fdf6bce90501288dab384
company,1619694000,"Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin",67112229,https://s.yimg.com/uu/api/res/1.2/0B0zCa4aUjfBl4rrebhdFw--~B/aD0xNTQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ff148e3d38a838153b30ad5fdf2612a3,ABMD,Yahoo,"Abiomed announces record revenue of $241 million , up 17% year over year, with 26.0% operating margin.",https://finnhub.io/api/news?id=eeb413a841dc96d0c7f478a6e20fcb14a451c85d721358ecade0ee74508824a7
company,1619689500,"ABIOMED, Inc. to Host Earnings Call",67112230,https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png,ABMD,Yahoo,"NEW YORK, NY / ACCESSWIRE / April 29, 2021 / ABIOMED, Inc. (NASDAQ:ABMD) will be discussing their earnings results in their 2021 Fourth Quarter Earnings call to be held on April 29, 2021 at 8:00 AM Eastern Time.",https://finnhub.io/api/news?id=3fc5656fa86ea48a998eae49c88845c23c456538b78b9fc558a721067b631199
company,1619684100,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",67114627,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nerve-cell-2213009_1920_25.jpg,ABMD,Benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 28)

Axonics, Inc. (NASDAQ:...",https://finnhub.io/api/news?id=6806a6eb1696b3877747d836ffe30d3c896546e7a9bcd241efeee5c7e9857e8f
company,1619682240,Abiomed: Fiscal Q4 Earnings Snapshot,67113814,,ABMD,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=edef04637a99abad60483677fcc7fb5b42a5e84b35d2c6f175bc8f919ebd5981
company,1619680606,Abiomed Inc. Q4 Earnings Climb,67111570,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1317008283,ABMD,Nasdaq,"(RTTNews) - Abiomed Inc. (ABMD) announced a profit for its fourth quarter that climbed from the same period last year.The company's bottom line totaled $56.86 million, or $1.24 per share.  This compares with $31.80 million, or $0.70 per share, in last year's fourth quarter.",https://finnhub.io/api/news?id=050420aa83d770a1998bcc5941b4a22f4b52283725a1a92daae17dc470066868
company,1619679615,Abiomed Q4 21 Earnings Conference Call At 8:00 AM ET,67111571,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?897255751,ABMD,Nasdaq,"(RTTNews) - Abiomed Inc. (ABMD) will host a conference call at 8:00 AM ET on April 29, 2021, to discuss Q4 21 earnings results.To access the live webcast, log on to https://edge.media-server.com/mmc/p/u4c589ep",https://finnhub.io/api/news?id=da28ffab2003975f9dfb17003d48885a98280ab997d23e3acc1f284e74b0fc52
company,1619679600,"Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin",67113815,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=06f1c6689d399f1a7416fe828e8421d22a51e644318cf4f961382e7b6ae869b8
company,1619678040,"Abiomed sees FY22 revenue $990M-$1.03B, consensus $998.13M",67113816,,ABMD,Thefly.com,"Abiomed sees FY22 revenue $990M-$1.03B, consensus $998.13M ABMD",https://finnhub.io/api/news?id=d326878794fc095feb1d3b921ed279e64a83765d10122b6b4f0b18e8733eea1c
company,1619677860,"Abiomed reports Q4 EPS $1.24, consensus $1.10",67113817,,ABMD,Thefly.com,"Abiomed reports Q4 EPS $1.24, consensus $1.10 ABMD",https://finnhub.io/api/news?id=f71e9545859bad448725d25247dddeea9ec9e2751dbd656936b3d37529851f48
company,1619659920,"Thursday Sector Laggards: Healthcare, Technology & Communications",67120093,,ABMD,Market News Video,,https://finnhub.io/api/news?id=c98d233a8d98fbbe7e798a3b4f364fb01d23b2ad532625530e09952b18cd82fd
company,1619639820,Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella,67003240,https://s.yimg.com/uu/api/res/1.2/mRRz4K8Dgru2bTMKrOu5kQ--~B/aD0yOTk7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6a70cd85b317ef070a1feda94a23a214,ABMD,Yahoo,"The final results of the physician-led National Cardiogenic Shock Initiative (NCSI) Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used, including placement of an Impella heart pump prior to revascularization (PCI). The study evaluated the outcomes of 406 consecutive patients who presented with acute myocardial infarction cardiogenic shock (AMICS) at 80 participating sites throughout the United States. The study shows a protocol-based approach to increasing survival rates in cardiogenic shock is reproducible in both academic and community hospital settings. Results were presented today by Babar Basir, DO, director of the acute mechanical circulatory support program at Henry Ford Hospital and co-principal investigator of the study, at the 2021 Society of Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions.",https://finnhub.io/api/news?id=b1c756407a123a332b294f8be20abc8b87267687284c75e423bb536b6db484d8
company,1619627580,Abiomed Inc. stock underperforms Wednesday when compared to competitors despite daily gains,67025622,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 3.09% to $351.17 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=02a4751ee293b582097e002355fa82ace3e588944e56d64ee4eb219a9bef94b7
company,1619625420,Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella,67007282,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=8659c132a5639b7aef6353434e103115f289ed69e473e975c6adeaa0ff01562b
company,1619611380,Dr. Paula A. Johnson Joins Abiomed Board of Directors,66936482,https://s.yimg.com/uu/api/res/1.2/pa3uLX3xjqIjWxnHDhVu_w--~B/aD00ODA7dz0zODQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8bb6e1ae0b46ae870bab7c954912bc68,ABMD,Yahoo,Dr. Paula Johnson joins the Abiomed Board of Directors,https://finnhub.io/api/news?id=a170ab3128b173ec49f815cda608f28fccf39d6caffec756403a0c5015aedb89
company,1619596980,Dr. Paula A. Johnson Joins Abiomed Board of Directors,66911814,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=ee0e9aeb259d9cf37436911b2ba8f9c9e8f930cf353ef08465b857fda6a8f27a
company,1619588340,"Newfound Research LLC Buys JPMorgan U.S. Quality Factor ETF, BTC iShares MSCI USA Min Vol ...",67042310,,ABMD,GuruFocus,GuruFocus Article or News written by insider and the topic is about: ,https://finnhub.io/api/news?id=4138a4c3c05ae0743f08fae5d2d656104c44adbf96c09ccb980940347d909499
company,1619541180,Abiomed Inc. stock underperforms Tuesday when compared to competitors,66762716,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 2.17% to $340.63 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=6d590bb6be241f4a14ff277221754ff659f451ad0544c463d6b82a79220eb2b1
company,1619454780,Abiomed Inc. stock outperforms competitors despite losses on the day,66762721,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slumped 0.81% to $348.20 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=008cdad15e85793d0b8b7383016348b45b83e2ed99f9994b2cb8ae2ff8bb79f0
company,1619383727,Is ABMD Stock A Buy or Sell?,66554775,https://s.yimg.com/uu/api/res/1.2/iV9XnhDcz9n6EeKEHCxH_Q--~B/aD02MDA7dz00NzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/991824deb0f1e14ba51a47933aa13a23,ABMD,Yahoo,"Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow nearly 900 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]",https://finnhub.io/api/news?id=9ea6a373df4cc62f6edbc01aaf2421816f8d41f2ad330c6c1c929aac4c539f02
company,1619256180,"The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx",68736639,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-3827745_1920_38_0_4.jpg,ABMD,Benzinga,Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...,https://finnhub.io/api/news?id=4aee1ab3a545c6de9e02872f8ba5aa30475b371c5a4e66b6e8977460fa8b72bb
company,1619191503,ABIOMED (ABMD) to Report Q4 Earnings: What's in the Cards?,66554778,https://s.yimg.com/uu/api/res/1.2/wTHMFcASXFw2GoAQpQr9tw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3b6072b30ddd43fb75a7496ced0a8833,ABMD,Yahoo,"Strong momentum of ABIOMED's (ABMD) Impella product line, both in Europe and Japan, is expected to have continued in the fiscal fourth quarter as well.",https://finnhub.io/api/news?id=f37f40e90f0558579eaa2939e617163a84ae90d35d12572b7fdf332e201f1cd2
company,1619109184,Abiomed (ABMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,66554779,https://s.yimg.com/uu/api/res/1.2/t6.OdXEVKQihFo9otNenfg--~B/aD01NjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9,ABMD,Yahoo,Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://finnhub.io/api/news?id=507708399ffcaf01170d0c73551e3a0bc53148df645f77778c8752fc599a4491
company,1619109180,Abiomed Inc. stock underperforms Thursday when compared to competitors despite daily gains,66199109,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.22% higher to $343.40 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=7304e0d85302cade18af4548d5532f5e09fcb64adbe75d63e11dd4f5b471735b
company,1619030372,Abiomed: Valuation Drivers Justify The Premium Over Peers,66189453,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1255404968/medium_image_1255404968.jpg,ABMD,SeekingAlpha,"Abiomed shares continue their positive outlook, driven by sales momentum in the Impella 5.0 & 5.5 platforms.",https://finnhub.io/api/news?id=ec8b0aec2f33906e74ee5686cc4148a03e0218d79a91366e60d3350fdb0176f9
company,1619022780,Abiomed Inc. stock outperforms competitors on strong trading day,66199111,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 3.80% to $342.64 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=b8112a49742483ab229f0e1e9ee4d809eecaea8784f42505c4cac0fc95d93c8c
company,1618936380,Abiomed Inc. stock outperforms market on strong trading day,66199112,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.21% higher to $330.10 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=907f1246b94d1833d699338d801800484da07bcdf66ce1343b34b6fb299b167a
company,1618849980,Abiomed Inc. stock outperforms market despite losses on the day,66199114,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. dropped 0.34% to $329.42 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=f0ac7a19d958502c65a0ab7cfa36c20c60f0aeb3b454adec6838bcf12a0bfa1a
company,1618590720,"Abiomed Inc. stock falls Friday, underperforms market",66163798,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 2.09% to $330.53 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=cf01678d5e743697c086e78fbb2141bda82149c801a6687533c058fea95f37dd
company,1618554224,"Is Abiomed, Inc.'s(NASDAQ:ABMD) Recent Stock Performance Tethered To Its Strong Fundamentals?",66554782,https://s.yimg.com/uu/api/res/1.2/8.7wAmlAutGU5iXFvarF9A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/542f5a72d5758cc977dad831c5295870,ABMD,Yahoo,Abiomed's (NASDAQ:ABMD) stock is up by a considerable 9.4% over the past month. Given the company's impressive...,https://finnhub.io/api/news?id=a199e24e68fcaa26e1f3c78bea3150effa9d71d0ff2efdbd9f82a20d2755b830
company,1618504380,Abiomed Inc. stock outperforms market on strong trading day,66163799,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 2.11% to $337.59 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=8c22550a4c97cde5f5ed400afaf9b7367ed1048050497d3268a83fbbb0a37a66
company,1618503840,"UnitedHealth, Abiomed rise; Delta, Virgin Galactic fall",66267520,,ABMD,"Associated Press, The",Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=d5a15b8a84bb183f48124361c55b75c4885b3401340fe4a2b7398617f84a4dd6
company,1618488180,First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella,66554785,https://s.yimg.com/uu/api/res/1.2/Z8zjGQpH0vGfeqaCQBCYAg--~B/aD0yNzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b694d94d08fbab97b3b0039d51bbb582,ABMD,Yahoo,"Abiomed (NASDAQ:ABMD) announced today that the first patient has been enrolled in PROTECT IV, a large, prospective, multi-center randomized controlled trial (RCT) that is designed to provide the level of clinical evidence needed to achieve a Class I guideline recommendation for Impella in high-risk percutaneous coronary intervention (HRPCI). The first patient was enrolled at Ascension St. John Hospital in Detroit by Dr. Ted Schreiber, chief of cardiology at Ascension St. John Macomb-Oakland Hospital and Dr. Amir Kaki, interventional cardiologist and director of mechanical circulatory support at Ascension St. John Hospital.",https://finnhub.io/api/news?id=0a6b1366053053a14ccd2e2613eaffa4043df59148332f75766630b57e4ba5a8
company,1618473780,First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella,66338068,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=db321c6a31fb8c3129efbd71aee7810a61fba3c45831ae3f72e3593f41ba30a7
company,1618470780,Abiomed says1st patient enrolled in PROTECT IV RCT of Impella,66338069,,ABMD,Thefly.com,Abiomed says1st patient enrolled in PROTECT IV RCT of Impella ABMD,https://finnhub.io/api/news?id=24f7e20c89a2df01049c1bb8c5d202b178200a8b5c74637dd5e74b8c1c639225
company,1618417980,Abiomed Inc. stock underperforms Wednesday when compared to competitors despite daily gains,66146226,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.19% higher to $330.60 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=ceebadc835a14656afa80ce3ee2df7417df112644788a9324e37745b05a0f508
company,1618331580,Abiomed Inc. stock underperforms Tuesday when compared to competitors,66143117,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 0.94% to $329.97 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=453edfeab2d277a3ed02b7abd837945cd6e6dec8d2f0c5e63edb684d84eb4f18
company,1618306740,"Chicago Capital, LLC Buys Lithia Motors Inc, Abiomed Inc, Ligand Pharmaceuticals Inc, Sells ...",66289124,https://static.gurufocus.com/photos/gurus/guru_logo_square.jpg,ABMD,GuruFocus,"Chicago Capital, LLC Buys Lithia Motors Inc, Abiomed Inc, Ligand Pharmaceuticals Inc, Sells RealPage Inc, Carvana Co, BlackLine Inc, Stocks: LAD,ABMD,LGND,NFLX,TRU,SPY,TRIP,PLNT,PLTR,BKNG,ESG, release date:Apr 13, 2021",https://finnhub.io/api/news?id=bf2c04fe4c9d1043973b4af3933d9e0ed61d3732d50da08bb6d7e181ce00c21a
company,1618245180,Abiomed Inc. stock underperforms Monday when compared to competitors,66143118,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slumped 0.21% to $333.11 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=45b280ef4836ce775be3c50912b6328139269e78890ca9a5c12ad400980c84e1
company,1618048800,3 Overlooked Healthcare Stocks to Buy Right Now,66554787,https://s.yimg.com/uu/api/res/1.2/w3XnfB_QInmvMxtDPfb3Sg--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/c25bd712d4334d8bf443bfa765bee97e,ABMD,Yahoo,"Here, I'll talk about three overlooked healthcare stocks to buy now for big reward potential well into the future.  Intuitive Surgical (NASDAQ: ISRG) has slipped about 6% since the start of the year.  This leader in robotic surgery holds more than 80% of the global market, a report from Informa Pharma Intelligence shows.",https://finnhub.io/api/news?id=ad9e18e493fa14dc992f17474fae9422cd7c49b4d005e531c41dec245bde2235
company,1617985920,Abiomed Inc. stock underperforms Friday when compared to competitors despite daily gains,66112443,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 1.23% to $333.81 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=fd95ebf43a2cdcce3a7309501e12baab5a2fe10816858beebd47e80d05bf969a
company,1617899580,"Abiomed Inc. stock rises Thursday, outperforms market",66109216,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 2.85% to $329.75 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=dd4517c53e4d1902c4f081fc55b43abb55a2b126eaa2c85aaac035d952424136
company,1617879600,Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification,66554789,https://s.yimg.com/uu/api/res/1.2/ymYFoxGkjFb80O4VlQh5Ug--~B/aD0xNTQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/d9fa5414e4e4ff1b73131c3426a0d177,ABMD,Yahoo,"Abiomed announces that on Thursday, April 29, 2021 the Company will release financial results for the fourth quarter of fiscal 2021.",https://finnhub.io/api/news?id=722473fcdcc6390e28e294a4ca721cc5261594bd9f54534fd5f20acb766a0bb7
company,1617869580,Abiomed Stock Appears To Be Fairly Valued,66338071,https://static.gurufocus.com/photos/gurus/guru_logo_square.jpg,ABMD,GuruFocus,"Abiomed Stock Appears To Be Fairly Valued, Stocks: ABMD, release date:Apr 08, 2021",https://finnhub.io/api/news?id=099922aebf936cf58998f39f88a0a450afcde2e4b669afd63356f32a76560ece
company,1617865200,Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification,66338072,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=b29697e4039cd837ddf9b9423cd923440e3bc90d1fb1dd09fb17dcc64c0b6ae6
company,1617813180,"Abiomed Inc. stock falls Wednesday, underperforms market",66109217,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. dropped 0.93% to $320.62 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=1c93e70a7f3160952c46802afcf5cc7531492e5881125d07814f72fba66897fa
company,1617726780,"Abiomed Inc. stock rises Tuesday, outperforms market",66109218,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.66% higher to $323.62 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=f57f7a8cc751bbbd372a9a706a70e3ba00503d6774255bc50673859d89b12f4c
company,1617640380,Abiomed Inc. stock outperforms competitors on strong trading day,66077778,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 1.95% to $321.50 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=7d2e77d2da29a7ffc5d7d5d92f6eafe3c2c0ab63f3340309e5d277f071509af4
company,1617528281,"RMR Wealth Builders Has $260,000 Stock Holdings in Abiomed, Inc. (NASDAQ:ABMD)",66054403,https://www.marketbeat.com/logos/abiomed-logo.gif,ABMD,https://www.thelincolnianonline.com,"RMR Wealth Builders reduced its stake in Abiomed, Inc. (NASDAQ:ABMD) by 26.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 803 shares of the medical equipment provider’s stock after selling 293 shares during the period. RMR Wealth Builders’ holdings in Abiomed were worth […]",https://finnhub.io/api/news?id=ce2fb4735b876447dab9f0479b31ea211bcf2596226af5637ba3938783c95d5d
company,1617446400,Buy These 3 Breakout Healthcare Stocks if There's a Sell-Off or Correction,66554792,https://s.yimg.com/uu/api/res/1.2/.D3Ex4qd0JjcxU0yIP8JKg--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/8b590217db5fc157909e60c7e6bbcaa1,ABMD,Yahoo,"Seeing a wall of red numbers on your brokerage account is usually a frightening experience, but it doesn't necessarily mean that you're a bad investor.  In this vein, I've been watching a group of three healthcare stocks that are currently on the pricey side.  STAAR Surgical Company (NASDAQ: STAA) makes exactly that: implantable lenses for ocular surgery.",https://finnhub.io/api/news?id=49f52c071aae6f518c2f57b121f9803bdad262a22ed2bbd014cce239c7c7bbb7
company,1617274620,Better Buy for the Next 10 Years: Abiomed vs. Guardant Heath,66554793,https://s.yimg.com/uu/api/res/1.2/YKwdcwHJs2SihziNAFcdrA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/56791a3d40737a177a8f077127c3c322,ABMD,Yahoo,"Abiomed (NASDAQ: ABMD) and Guardant Health (NASDAQ: GH) both sport market caps just north of $13 billion, but these companies represent very different ways to invest in healthcare stocks for the next decade.  Abiomed is the maker of Impella, a temporarily implanted device meant to help protect the heart when it's been damaged or during complex procedures.  Guardant Health, meanwhile, utilizes a blood test to perform a liquid biopsy to determine whether a patient has cancer, and if so, what treatment regimens would be best.",https://finnhub.io/api/news?id=3f0daaf0f62211ea2f874adc7f9db7abfd93a402f4da5af2f0623e07d1f35fbb
company,1617208380,Abiomed Inc. stock outperforms competitors on strong trading day,66011339,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 2.86% to $318.73 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=a28ad739d75c9bfc241b48aa31f90ee9881e70b694c53fdcf77765d01e1b7a8a
company,1617189431,"Zacks Industry Outlook Highlights: Natus Medical, IDEXX Laboratories, Hologic, Thermo Fisher Scientific and Abiomed",66532418,https://s.yimg.com/uu/api/res/1.2/f_ivn8Bjpou.vwuiQ0Xriw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/67d55099b4ab8c0c454774738660eba8,ABMD,Yahoo,"Zacks Industry Outlook Highlights: Natus Medical, IDEXX Laboratories, Hologic, Thermo Fisher Scientific and Abiomed",https://finnhub.io/api/news?id=c5f897f903c3074ccd1890fb204ad27b86dffb16d96af52b506b17ab7374ad47
company,1617121980,"Abiomed Inc. stock rises Tuesday, outperforms market",65987554,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 1.34% to $309.88 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=ed6a4d015b01d45d2cfd32843c8ab66c37ee516e58e5e22b99663822105ea3cc
company,1616776380,Abiomed Inc. stock outperforms market on strong trading day,65278538,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 2.47% to $301.40 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=5f6a2f1eddf12f97f22ec09d7482a324d3f60b64033858f984bb541c7e2d6772
company,1616689980,"Abiomed Inc. stock falls Thursday, underperforms market",65278539,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. sank 0.02% to $294.14 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=af5eb62e4695fd0594f6bc5c43a342bf82f0fb1756b352a59b7fa4bacb01294a
company,1616603580,"Abiomed Inc. stock falls Wednesday, underperforms market",64835290,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 1.48% to $294.21 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=191692808cb75ec4cb2923ff972e3dc3a56b6acf656fecc8443576bd2b316a09
company,1616517180,"Abiomed Inc. stock falls Tuesday, underperforms market",64813811,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 2.46% to $298.62 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=c4bad076f5707181438d9f48c8acc2211f3b0fbf7b8dbfaab8f7b00873013623
company,1616430780,Abiomed Inc. stock outperforms market on strong trading day,64795475,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 2.12% to $306.16 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=988dec53b8924a240ebdcedf0c8fc109437502d262218ef0217abf9fa7c2f8a3
company,1616326620,This Company Will Fix the Hidden COVID Danger to Come,66554797,https://s.yimg.com/uu/api/res/1.2/ZOTQHv2HpSvZD.aS0FuB0g--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/dd58c1fd15a8704466e31996e4eb1a9e,ABMD,Yahoo,"While much ado has rightfully been made of the COVID public health disaster, we haven't seen a lot of long-term forward-looking analysis -- few prognosticators seem focused on skating to where the puck is going.  Throughout COVID, I read a whole lot about the possibilities of investing in the vaccine (Moderna, Pfizer, Johnson & Johnson), ventilators (Resmed), and treatments (Gilead) -- but I didn't hear many cogent arguments focused around what are sure to be the longer-term public health implications of COVID-19.  A July 2020 study done in Frankfurt, Germany, of patients who had recovered from COVID showed that 60% had ongoing heart problems after recovery, independent of their pre-existing conditions.",https://finnhub.io/api/news?id=7073c607479ec776aa9b9d66a796025dc04a3fe1c2969ac724481c65bb2d492a
company,1616171580,Abiomed Inc. stock outperforms competitors on strong trading day,64764470,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.32% higher to $299.81 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=429aa8631e62c61aca0cc48238e819197f82d2eeae66c1001fde79f4e5b96cfb
company,1616085180,"Abiomed Inc. stock falls Thursday, underperforms market",64740081,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 1.90% to $298.86 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=aeecafe847fa141648793896bef93b984409299a1f35e435e1f601cfa1fc6be3
company,1615998780,Abiomed Inc. stock underperforms Wednesday when compared to competitors,64717713,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 1.31% to $304.66 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=1feb4809d3e58556cc78b4f33ac6c2c053baecef8f97d3156563bfc9fd8b9fbe
company,1615912380,Abiomed Inc. stock outperforms market on strong trading day,64694853,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.49% higher to $308.69 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=81fd2e3942a87351e3de8194d7aeaf6bbf480dff6727f2e60c04275863d05052
company,1615891920,Abbott confirms to Bloomberg suspension of trial enrollment,66338073,,ABMD,Thefly.com,Abbott confirms to Bloomberg suspension of trial enrollment ABT ABMD,https://finnhub.io/api/news?id=d3ff3d00a557659298e07a36103b858843b43b9b3edff55faa89951d105dd669
company,1615889640,"Abbott study challenging Abiomed`s Impella halted, says Piper Sandler",66338074,,ABMD,Thefly.com,"Abbott study challenging Abiomed's Impella halted, says Piper Sandler Piper Sandler ABMD ABT",https://finnhub.io/api/news?id=b35c602805322ee1ff35bb715bcf1c55f01659733647a85961d3a1381c81312f
company,1615889580,Abiomed up 1% after Clinicaltrial.gov shows Abbott study halt,66338075,,ABMD,Thefly.com,Abiomed up 1% after Clinicaltrial.gov shows Abbott study halt ABMD ABT,https://finnhub.io/api/news?id=98bb4fb395134102eef2d4fd81041a39db8c591907a6570a2a8e05c47fd5fd3e
company,1615889520,"Abbott study challenging Abiomed`s Impalla halted, says Piper Sandler",66338076,,ABMD,Thefly.com,The Fly is a leading digital publisher of real-time financial news. The Fly team scours all sources of company news and delivers short-form stories consisting of only market moving content.,https://finnhub.io/api/news?id=de94556d4e84eb83d3e23102f247b57f6ede65f48b51f3ebdf141c3b7b029942
company,1615568280,"Abiomed Inc. stock falls Friday, underperforms market",64644350,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 0.27% to $303.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=445031dc4735999b15fb9eafb3009fc9e1206d0eb1a2faccea632d0ed1117d6b
company,1615481880,"Abiomed Inc. stock rises Thursday, outperforms market",64618767,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 2.73% to $304.37 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=31a97c389289af773368b3047fda91c0c9579ffbe62c662c42db6f5ec3c8a368
company,1615480804,CMD or ABMD: Which Is the Better Value Stock Right Now?,66554799,https://s.yimg.com/uu/api/res/1.2/Fj4TPQveJWuth16WIsEVAw--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be,ABMD,Yahoo,CMD vs. ABMD: Which Stock Is the Better Value Option?,https://finnhub.io/api/news?id=bb2052f61e2ceeea06a68acd31466d4ca76dbe6d1c92ef3767d679210f663422
company,1615395480,"Abiomed Inc. stock falls Wednesday, underperforms market",64588726,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 0.18% to $296.28 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=fd00b2e9c3158200d3d4005d225c30d1f338da441879215c86cbda42363ed6be
company,1615374000,Could Abiomed Be a Millionaire-Maker Stock?,66554801,https://s.yimg.com/uu/api/res/1.2/DuGPmBJS_oGQh5YTcv2yCg--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/8919d0e28c4e29f521304ed211e78d83,ABMD,Yahoo,"Abiomed (NASDAQ: ABMD) shares have tripled in value over the past five years.  The U.S. Food and Drug Administration has authorized its pumps for the treatment of some hospitalized coronavirus patients.  In more good news, the company reported record revenue in the most recent quarter.",https://finnhub.io/api/news?id=0a51b8d24c1db7b46f8258bd4dbc4ecb31d23ece7626836935c4642646d51d39
company,1615309080,"Abiomed Inc. stock rises Tuesday, outperforms market",64555962,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 3.81% to $296.80 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=4b5fd4e2671d5268ecba535ee80431791fdffe2c2f06789469a0aee9afb77e1c
company,1615300392,"Tuesday Sector Leaders: Technology & Communications, Healthcare",64663739,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?97366384,ABMD,Nasdaq,"Looking at the sectors faring best as of midday Tuesday, shares of Technology & Communications companies are outperforming other sectors, up 3.5%.  Within that group, Enphase Energy Inc. (Symbol: ENPH) and Monolithic Power Systems Inc (Symbol: MPWR) are two large stocks lea",https://finnhub.io/api/news?id=98f4aa3dc319340e2c3a473418071dada832d49434551175ca6b1017eb2b62de
company,1615222680,Abiomed Inc. stock underperforms Monday when compared to competitors,64537329,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 5.08% to $285.92 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=f4383210d0da33111029fe3439b875fab95c543fca5fe205b9ee211d14370b02
company,1615150973,Align Your Portfolio For Growth With Align Technology,64519526,https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png,ABMD,SeekingAlpha,Fast-growing Align Technology has a premium product thanks to its intellectual property in orthodontic treatment.,https://finnhub.io/api/news?id=abbfdd43feb07a3bc83985a1a2f97bfca0daefc5257535864dacfee038663362
company,1614963480,"Abiomed Inc. stock rises Friday, still underperforms market",64493335,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 1.89% to $301.22 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=6ead62d6bbc1292f13cd1c40855faa1063fd391ccc2cad5a1f815738c24b7e35
company,1614940620,ABIOMED Breaks Below 200-Day Moving Average - Notable for ABMD,66338077,,ABMD,Market News Video,"In trading on Friday, shares of ABIOMED, Inc - (ABMD) crossed below their 200 day moving average of $284.77, changing hands as low as $282.23 per share. - ABMD.",https://finnhub.io/api/news?id=d1616b2e0dce02bf2884126b0ba98d0bd1793d0e96105582534fd5dcce8527fe
company,1614902400,Resumen: MEDCERT autoriza el uso del procedimiento de acceso único con las vainas introductoras Impella CP en Europa,64487493,https://mms.businesswire.com/media/20210305005465/es/863186/23/Single_Access.jpg,ABMD,businesswire,"Tras consultar con MEDCERT GmbH, su organismo notificado, Abiomed va a poner en marcha en Europa el procedimiento de entrada única Impella CP con vain",https://finnhub.io/api/news?id=fdc0e477101b2af2104e36f3e221c87dfcaa5d0638ee586eb985c16b8294a350
company,1614895080,"Abiomed Inc. stock falls Thursday, underperforms market",64467627,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 3.89% to $295.63 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=7dbe25dc3373b4c05b341d05de147a2c2b5b2a5cd3eef4f8ee98898d1d8279b7
company,1614866400,MEDCERT Enables the Use of the Single Access Procedure with Impella CP Introducer Sheaths in Europe,66554804,https://s.yimg.com/uu/api/res/1.2/3FmUXd8.Og8HS2TsSl_yRQ--~B/aD0yNTM7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c2d984164ccddbf0b4e2c77783d194f8,ABMD,Yahoo,"Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single access procedure with Impella CP introducer sheaths for the treatment of heart disease in Europe.",https://finnhub.io/api/news?id=fc84ea576404a69e587e3b4b8fbcc672b7d9c0324980dc6ff4f1d766ee6d38fa
company,1614848400,MEDCERT Enables the Use of the Single Access Procedure with Impella CP Introducer Sheaths in Europe,66338079,,ABMD,Business Wire,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.,https://finnhub.io/api/news?id=a5186d0f7d0906016a8794cbc9da2f13ef78876083e5e40f0bbae8314d433465
company,1614816000,MEDCERT autorise l'utilisation de la procédure d'accès unique des gaines d'introduction Impella CP en Europe,64466535,https://mms.businesswire.com/media/20210304006116/fr/863186/23/Single_Access.jpg,ABMD,businesswire,Après consultation de son organisme notifié - MEDCERT GmbH - Abiomed lance la procédure d'accès unique des gaines d'insertion Impella CP pour le trait,https://finnhub.io/api/news?id=b8cafd5f267c70138135741e0141f6bfbad19717a55abad1da26a4dd0cd9bd61
company,1614816000,MEDCERT autorise l'utilisation de la procédure d'accès unique des gaines d'introduction Impella CP en Europe,64466533,https://mms.businesswire.com/media/20210304006116/fr/863186/23/Single_Access.jpg,ABMD,businesswire,Après consultation de son organisme notifié - MEDCERT GmbH - Abiomed lance la procédure d'accès unique des gaines d'insertion Impella CP pour le trait,https://finnhub.io/api/news?id=fac66b1ec3e88e1663c680585bb80a2e370deca82cc4d79666a8ffd3da49af81
company,1614816000,MEDCERT autorise l'utilisation de la procédure d'accès unique des gaines d'introduction Impella CP en Europe,64466447,https://mms.businesswire.com/media/20210304006116/fr/863186/23/Single_Access.jpg,ABMD,businesswire,Après consultation de son organisme notifié - MEDCERT GmbH - Abiomed lance la procédure d'accès unique des gaines d'insertion Impella CP pour le trait,https://finnhub.io/api/news?id=b80c3d132e0759349e2402a2efff959265dcf38122b1c817831d8a4fee60a7be
company,1614816000,Riassunto: MEDCERT autorizza l'uso della procedura di accesso singolo con le guaine introduttive Impella CP in Europa,64465764,https://mms.businesswire.com/media/20210304006036/it/863186/23/Single_Access.jpg,ABMD,businesswire,"A seguito della consultazione con il suo organismo notificato, MEDCERT GmbH, Abiomed sta introducendo la procedura di accesso singolo con guaine intro",https://finnhub.io/api/news?id=0d437579d829f412f452a2c66703ce9701bb75ba02a12bd650e9413b0873069b
company,1614816000,Samenvatting: MEDCERT maakt het gebruik van de Single Access Procedure met Impella CP Introducer Sheaths in Europa mogelijk,64462098,https://mms.businesswire.com/media/20210304005939/nl/863186/23/Single_Access.jpg,ABMD,businesswire,"Na overleg met haar aangemelde instantie, MEDCERT GmbH, introduceert Abiomed de single access-procedure met Impella CP-introducerhulzen voor de behand",https://finnhub.io/api/news?id=0c8a752014bc19217a900d4b5b63220606ca7d61c2749289fe117bae12379450
company,1614816000,MEDCERT ermöglicht in Europa die Anwendung des Single-Access Verfahrens mit Impella CP Einführschleusen,64451892,https://mms.businesswire.com/media/20210304005575/de/863186/23/Single_Access.jpg,ABMD,businesswire,Abiomed führt nach Rücksprache mit seiner Benannten Stelle MEDCERT GmbH bei der Behandlung von Herzerkrankungen ab sofort auch in Europa das Single-Ac,https://finnhub.io/api/news?id=f70e745518752e31510de79216d81da14d50417bb5744fcdeb8d4f8dffe1c7fd
company,1614816000,MEDCERT Enables the Use of the Single Access Procedure with Impella CP Introducer Sheaths in Europe,64451891,https://mms.businesswire.com/media/20210304005331/en/863186/23/Single_Access.jpg,ABMD,businesswire,"Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single access procedure with Impella CP introducer sheaths for",https://finnhub.io/api/news?id=99b4d130b5e6209915da371f25e058c8e63db9ad56276add6447bddf89de0ea0
company,1614790680,"Abiomed Inc. stock falls Wednesday, underperforms market",64439987,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 5.44% to $307.60 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=7d2696b172d301fd0add267d412be0398d9f4278c7bbaf449d427a58e55143f5
company,1614704280,Abiomed Inc. stock outperforms market on strong trading day,64401411,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.32% higher to $325.31 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=e21b91162b1bcf3e3de9db3c22f05c5d54743e7f9da8e0715378b6410f61fc9a
company,1614659175,What Do The Returns On Capital At Abiomed (NASDAQ:ABMD) Tell Us?,66554807,https://s.yimg.com/uu/api/res/1.2/8.7wAmlAutGU5iXFvarF9A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/542f5a72d5758cc977dad831c5295870,ABMD,Yahoo,"There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...",https://finnhub.io/api/news?id=a196cc6a2381b84370e22771da2dd80ae2376d0346e0027fcd7dd921ac6b35d2
company,1614617880,Abiomed Inc. stock underperforms Monday when compared to competitors,64364676,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. dropped 0.09% to $324.26 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=a19a96e5be110c3caec1ee01f5b5133b8b7613f8bb77600b56044ca2b0deadbe
company,1614443404,Abiomed (ABMD) Down 8.6% Since Last Earnings Report: Can It Rebound?,66554808,https://s.yimg.com/uu/api/res/1.2/QOfludHza1dTKV8R6Coeiw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9,ABMD,Yahoo,Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,https://finnhub.io/api/news?id=17741c841cd4c14374152e2e1cc10d09334de5f3f5ca3cc4cc623bb08d5e7414
company,1614358680,Abiomed Inc. stock outperforms market on strong trading day,64319850,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 1.27% to $324.55 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=24dcd70eb501eacaa5a9f78fa728e7a9d1b8b878ceb986940f336de96288d16a
company,1614272280,Abiomed Inc. stock outperforms market despite losses on the day,64319851,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 1.02% to $320.47 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=35da157a649c6e5704df505ad837303607570584dccfd7b5e28d2b10d7d79c31
company,1614185880,"Abiomed Inc. stock rises Wednesday, still underperforms market",64158640,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.65% higher to $323.78 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=06ed6d29c302dea3f515167508f2d756a1be6ac318575be25fe98a54f6b79085
company,1614099480,Abiomed Inc. stock outperforms competitors despite losses on the day,64158672,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. sank 0.33% to $321.69 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=c99edd265df4c9c9d08bcc3a5ad107be9ed76825244773dbbdc1c65cde16270d
company,1614013080,Abiomed Inc. stock underperforms Monday when compared to competitors,63852539,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 2.78% to $322.75 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=8e7b577aeb82682927568ba7227b7203d8c5266796adcce63f112b9c01dc06fc
company,1613753880,Abiomed Inc. stock outperforms competitors on strong trading day,63705754,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 3.07% to $331.97 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=64d0da3a411b38e22fbc425826be41f0c6ea665449187a030188ba4cedcdd8f1
company,1613667480,Abiomed Inc. stock outperforms market on strong trading day,63671371,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 1.83% to $322.08 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=7441d9066ba565f8189a42cd5c8132e4356bc506a24e39eab0b410ed80b10193
company,1613642400,Validea Peter Lynch Strategy Daily Upgrade Report - 2/18/2021,63791018,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1045707089,ABMD,Nasdaq,The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.ELLINGTON RESIDENTIAL MORTGA,https://finnhub.io/api/news?id=692f30f1933a4a1298446e900cf5d0cec5e612da448dcbb6740bd05b6a1e18c9
company,1613606400,Abiomed beruft Dr. Myron Rolle in das Board of Directors,63666174,https://mms.businesswire.com/media/20210218005874/de/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) gibt die Berufung von Myron Rolle, MD, in das Board of Directors von Abiomed mit sofortiger Wirkung bekannt. Dr. Rolle wird als",https://finnhub.io/api/news?id=48e6f93a63fefb2948d9bec5947391a46a43dc7b40741e0b378e5088d5cf6cf9
company,1613606400,Abiomed beruft Dr. Myron Rolle in das Board of Directors,63666150,https://mms.businesswire.com/media/20210218005874/de/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) gibt die Berufung von Myron Rolle, MD, in das Board of Directors von Abiomed mit sofortiger Wirkung bekannt. Dr. Rolle wird als",https://finnhub.io/api/news?id=c5c514b631a11d31376a9914bd229add86687b9e673b23e623845d54c5b4769a
company,1613606400,Resumen: Abiomed anuncia el nombramiento del Dr. Myron Rolle como miembro del Consejo de Administración,63666141,https://mms.businesswire.com/media/20210218005880/es/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) anuncia el nombramiento de Myron Rolle, MD, como miembro del Consejo De Administración de la empresa, con efecto inmediato. El",https://finnhub.io/api/news?id=5e3a6a7e1f92e9ca71aacbdf189671a5de285ba30f42c7f0b386c6f499640fbd
company,1613606400,Resumen: Abiomed anuncia el nombramiento del Dr. Myron Rolle como miembro del Consejo de Administración,63666140,https://mms.businesswire.com/media/20210218005880/es/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) anuncia el nombramiento de Myron Rolle, MD, como miembro del Consejo De Administración de la empresa, con efecto inmediato. El",https://finnhub.io/api/news?id=4c85acd549dbdb0cb227bf8139211de796ceebaabe7fd53585cffc3730db8fb4
company,1613606400,Abiomed beruft Dr. Myron Rolle in das Board of Directors,63666094,https://mms.businesswire.com/media/20210218005874/de/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) gibt die Berufung von Myron Rolle, MD, in das Board of Directors von Abiomed mit sofortiger Wirkung bekannt. Dr. Rolle wird als",https://finnhub.io/api/news?id=2cae750a30bad915e11c2064fa2c433ad68d0406f2fbc39e6048b2a464943667
company,1613606400,Resumen: Abiomed anuncia el nombramiento del Dr. Myron Rolle como miembro del Consejo de Administración,63666093,https://mms.businesswire.com/media/20210218005880/es/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) anuncia el nombramiento de Myron Rolle, MD, como miembro del Consejo De Administración de la empresa, con efecto inmediato. El",https://finnhub.io/api/news?id=0ffa32eda90a938ec96608582e64a9d9740b7beb5652bc7eac13c99e6edb464c
company,1613588521,Abiomed : annonce la nomination du docteur Myron Rolle au conseil d'administration | Zone bourse,64454074,https://www.zonebourse.com/images/twitter_ZB_fdblanc.png,ABMD,https://www.zonebourse.com,,https://finnhub.io/api/news?id=f0613b8c1d30b03eaf658f6f2e7ac4e05bcf296fb78d4fbc78d26e3bec26af0b
company,1613588521,Abiomed : annonce la nomination du docteur Myron Rolle au conseil d'administration | Zone bourse,63718119,https://www.zonebourse.com/images/twitter_ZB_fdgris.png,ABMD,https://www.zonebourse.com,,https://finnhub.io/api/news?id=9213d00357f82cc6e1bb90386453a856edbc986f48bd8be7d131cdd6f0aa2135
company,1613581080,"Abiomed Inc. stock falls Wednesday, underperforms market",63629144,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 2.01% to $316.30 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=c384e31345f939425e32db4a4f4775e50e9b91b6e6fe8d19463f3a38fab4e0ea
company,1613566980,Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors,66554810,https://s.yimg.com/uu/api/res/1.2/uZFoIzI_dPHTGqLUM0A3Kw--~B/aD0zMjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/53ee923e7bf89bbd07d4067ef06c62be,ABMD,Yahoo,"Abiomed announces the appointment of Myron Rolle, MD, to the Abiomed Board of Directors.",https://finnhub.io/api/news?id=c22c4fdb3a13dc56c1ac3002792fe3c2c71a054681a1dec08b95d60402f5ec3a
company,1613563200,Abiomed to Present at Upcoming Investor Conferences,66554812,https://s.yimg.com/uu/api/res/1.2/xmOIfqJFzrOZ4W6AHVC0EQ--~B/aD0xNTQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/56ced4bcd23821e24b28f9ce5f685ffa,ABMD,Yahoo,Abiomed to present at upcoming investor conferences.,https://finnhub.io/api/news?id=6664df9c086ca7b1d164bb38bb25b93baa31426f9996a632dd206a462677e168
company,1613520000,Riassunto: Abiomed annuncia la nomina del Dott. Myron Rolle a membro del consiglio di amministrazione,63626982,https://mms.businesswire.com/media/20210217005980/it/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) annuncia la nomina di Myron Rolle, MD, a membro del consiglio di amministrazione dell'azienda, con effetto immediato. Il Dott.",https://finnhub.io/api/news?id=4e5744cd8ca95387e273b7db0fdb38eb68d478e64f0a73063ac2e1883f48c3ac
company,1613520000,Abiomed annonce la nomination du docteur Myron Rolle au conseil d’administration,63622593,https://mms.businesswire.com/media/20210217005876/fr/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ : ABMD) annonce la nomination avec effet immédiat de Myron Rolle, docteur en médecine, au conseil d’administration d’Abiomed. Le docte",https://finnhub.io/api/news?id=7f264c7aec79a6887b697ff014b1aa809b58f2755f965643e04b2e949fa77560
company,1613520000,Abiomed kondigt de benoeming van Dr. Myron Rolle aan als lid van de Raad van Bestuur,63617263,https://mms.businesswire.com/media/20210217005697/nl/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) kondigt de benoeming aan van Myron Rolle, MD, in de Raad van Bestuur van Abiomed, met onmiddellijke ingang. Dr. Rolle zal diene",https://finnhub.io/api/news?id=9748d9ce2844949eaccf238ecfd96ef2d049686cc8ab3b62937ebf46d1c459a9
company,1613520000,Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors,63612648,https://mms.businesswire.com/media/20210217005546/en/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed announces the appointment of Myron Rolle, MD, to the Abiomed Board of Directors.",https://finnhub.io/api/news?id=b8b2e696a777405743d9dfc8917d61c10b7a0b34ac1c12df0f5668b2788943a2
company,1613520000,Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors,63612646,https://mms.businesswire.com/media/20210217005546/en/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed announces the appointment of Myron Rolle, MD, to the Abiomed Board of Directors.",https://finnhub.io/api/news?id=7480f828523ade5d0d41f7814a18ee92301fb7c4dcc5992d8c1524bbed66500c
company,1613520000,Abiomed Announces Appointment of Dr. Myron Rolle to Board of Directors,63612397,https://mms.businesswire.com/media/20210217005546/en/859430/23/MYRON_ROLLE_Headshot_%281%29.jpg,ABMD,businesswire,"Abiomed announces the appointment of Myron Rolle, MD, to the Abiomed Board of Directors.",https://finnhub.io/api/news?id=cac1d358091668f69c287341961f55c0552fd36c7f4d59984cbf15553f8a9952
company,1613494680,"Abiomed Inc. stock falls Tuesday, underperforms market",63593327,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 1.70% to $322.78 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...",https://finnhub.io/api/news?id=556ceb3261c1f5fd96fb3549fb475630d98f8888371345b9a72ae07f63394305
company,1613149080,"Abiomed Inc. stock rises Friday, outperforms market",63530369,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 1.68% to $328.36 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=2db3f44cb876bed8aea848adbc929cee4b9c7e831a05ae5bf3591caee60c8cb8
company,1613062680,"Abiomed Inc. stock falls Thursday, underperforms market",63509132,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 0.49% to $322.93 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=60ad36ea232733e0dc1891b84216f25eb95e42a15f97f3c9b4939d709feb1cba
company,1613062024,Why You Should Retain Abiomed (ABMD) Stock in Your Portfolio,66554814,https://s.yimg.com/uu/api/res/1.2/KF.RcOL3NCis8EjppApmOg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/13810238994cd44cc10997bfcd271168,ABMD,Yahoo,"Investor confidence is high in Abiomed (ABMD) stock, courtesy of its solid prospects.",https://finnhub.io/api/news?id=b2017deca5b89585ac158a4f836d62d25f891004e76011e6fcbeeb984cd1d967
company,1612976280,Abiomed Inc. stock outperforms market on strong trading day,63477239,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.01% higher to $324.51 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=59952709f5aad877fb608e0d154ea79352d2763fb91113a9230bcc05fdaea041
company,1612889880,"Abiomed Inc. stock falls Tuesday, underperforms market",63370021,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 0.42% to $324.48 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=1a683bfdb3ca17a76b3743f6c939d9a1c8e491f347c5808025ad31dee681d124
company,1612803480,"Abiomed Inc. stock falls Monday, underperforms market",63063640,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 0.61% to $325.86 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=519e244f291da143d7c83bc7508deaae684bc6476128ef5a83e3bb52ea6c12b7
company,1612544280,Abiomed Inc. stock outperforms competitors on strong trading day,63044614,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.95% higher to $327.85 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=a60c708ff86c0fe1e2a1468e7c001b54bf5b8ef7a31b75c0663a87ad9f5c5ef2
company,1612457940,"Abiomed Inc. stock falls Thursday, underperforms market",63044615,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. dropped 0.44% to $324.78 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=f43d8353e50a3b4f10156d64abda42558707a0de9b93548237d94d10074f452f
company,1612442820,"Where to Invest $10,000 Right Now",66554816,https://s.yimg.com/uu/api/res/1.2/5fI8YtAKUzFZZw1xjnYtJg--~B/aD0xMDAxO3c9MTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/7fbe8fa5ad2cbfaf8de749260070bdb8,ABMD,Yahoo,"Abiomed's (NASDAQ: ABMD) heart pumps assist or take over the pumping function to allow the heart to rest.  The ventricular assist device market, at a compound annual growth rate of 20%, may reach $3.5 billion by 2027, according to a Global Industry Analysts report.  Abiomed's revenue and general financial health are another plus.",https://finnhub.io/api/news?id=7df4a23cbbe03c5c4da51053aa57d17f868cbe03acf1dc6ed0b5f92330e1b74e
company,1612424820,"Where to Invest $10,000 Right Now",63475813,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?928036285,ABMD,Nasdaq,The S&P 500 slipped 1.1% in January to finish the first month of the year in the doldrums. And the coronavirus pandemic seems far from over. But these two elements shouldn't discourage us from investing in stocks that have proven themselves over the long term -- and fared wel,https://finnhub.io/api/news?id=91a7ad22661c0e9aa25801a619dd44c6e15232264c2eb4a109b2424b234e8b7e
company,1612371540,"Abiomed Inc. stock falls Wednesday, underperforms market",62685290,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 6.21% to $326.23 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=6fd4fdb588dff09db062ea969ef204e4713aa3adf13edc7869ddbe2f38f3a9d2
company,1612362993,"Wednesday Sector Laggards: Healthcare, Utilities",63475814,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?607997791,ABMD,Nasdaq,"Looking at the sectors faring worst as of midday Wednesday, shares of Healthcare companies are underperforming other sectors, showing a 0.5% loss.  Within that group, PerkinElmer, Inc. (Symbol: PKI) and ABIOMED, Inc. (Symbol: ABMD) are two large stocks that are lagging, showing",https://finnhub.io/api/news?id=c625b5797b5e5b82e4fa14f3987cb7094fc7a0072cb560abb299d6af93c30843
company,1612285080,Abiomed Inc. stock underperforms Tuesday when compared to competitors despite daily gains,62662053,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 1.75% to $347.84 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=d6b4e68d7616c018991f0c7ced8e707e045df38ea7ceba98bf59fbf90c2beb59
company,1612224000,"Aramark Sets New Climate Goal, Commits to Reducing Greenhouse Gas Emissions by 15% by the End Of 2025",62647271,https://mms.businesswire.com/media/20210202005275/en/856253/23/People_Planet_Graphic_Final_Updated_revGL.jpg,ABMD,businesswire,"Just one year after introducing its sustainability plan, Be Well. Do Well., Aramark (NYSE: ARMK), the leading U.S.-based provider of food, facilities",https://finnhub.io/api/news?id=448f6a245f24e21fa0fd0ab09b543b335d1b1b56559c7774c30971ec1b844525
company,1612224000,"Aramark Sets New Climate Goal, Commits to Reducing Greenhouse Gas Emissions by 15% by the End Of 2025",62647270,https://mms.businesswire.com/media/20210202005275/en/856253/23/People_Planet_Graphic_Final_Updated_revGL.jpg,ABMD,businesswire,"Just one year after introducing its sustainability plan, Be Well. Do Well., Aramark (NYSE: ARMK), the leading U.S.-based provider of food, facilities",https://finnhub.io/api/news?id=9ac91283c9df9b5a6c0b8033c80a274d406a16bd88e1742b948c6a6ca515be41
company,1612224000,"Aramark Sets New Climate Goal, Commits to Reducing Greenhouse Gas Emissions by 15% by the End Of 2025",62647251,https://mms.businesswire.com/media/20210202005275/en/856253/23/People_Planet_Graphic_Final_Updated_revGL.jpg,ABMD,businesswire,"Just one year after introducing its sustainability plan, Be Well. Do Well., Aramark (NYSE: ARMK), the leading U.S.-based provider of food, facilities",https://finnhub.io/api/news?id=eaa4cce8255485a8818fc03104add794847b62ff111d62ecb29e4ef2bbd51dbb
company,1612198680,Abiomed Inc. stock underperforms Monday when compared to competitors,62637522,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 1.83% to $341.86 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=4702999e3fabfab1aa91552edd7dde50fde22aea75029a13e62705b27fb9d0a2
company,1612137600,Cardiac Insight Comments on Medicare Administrative Contractor Novitas Rate Publication,62634287,https://mms.businesswire.com/media/20210201005891/en/856159/23/CI_logo.jpg,ABMD,businesswire,"Cardiac Insight, Inc. comments on the recent reimbursement rates published by Medicare Administrative Contractor Novitas Solutions.",https://finnhub.io/api/news?id=c371810ad2027c33eba1f87c1ac3a96c29e6ecbadccc40101364887ce2bbb8f7
company,1612137600,Worldwide Wireless ECG Devices Industry to 2025 - Declining Cost of Wireless Technologies is Driving Growth - ResearchAndMarkets.com,62630504,https://mms.businesswire.com/media/20210201005743/en/371054/23/ResearchAndMarkets_800px.jpg,ABMD,businesswire,The,https://finnhub.io/api/news?id=a0a5ec13dfe10cf07cbc57e8b2895aadac6a7466f68479793d64d1459b0a5dbc
company,1612137600,Resumen: Gran ensayo clínico presentado en STS 2021 revela una tasa de supervivencia del 79 % tras el uso de Impella 5.5 con SmartAssist,62630460,https://mms.businesswire.com/media/20210201005696/es/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) anuncia que un gran estudio con 356 pacientes tratados con Impella 5.5 con SmartAssist en 16 centros de EE. UU. y Alemania ha r,https://finnhub.io/api/news?id=7e35e7f85545b8da9fb8b29e9a01758372b6cc09194448e86ae32b7e84ae5a00
company,1612137600,Resumen: Gran ensayo clínico presentado en STS 2021 revela una tasa de supervivencia del 79 % tras el uso de Impella 5.5 con SmartAssist,62630458,https://mms.businesswire.com/media/20210201005696/es/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) anuncia que un gran estudio con 356 pacientes tratados con Impella 5.5 con SmartAssist en 16 centros de EE. UU. y Alemania ha r,https://finnhub.io/api/news?id=c3688595642014f847077061de242df427a02f3421ac689f1eef2154574efa80
company,1612137600,Resumen: Gran ensayo clínico presentado en STS 2021 revela una tasa de supervivencia del 79 % tras el uso de Impella 5.5 con SmartAssist,62630456,https://mms.businesswire.com/media/20210201005696/es/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) anuncia que un gran estudio con 356 pacientes tratados con Impella 5.5 con SmartAssist en 16 centros de EE. UU. y Alemania ha r,https://finnhub.io/api/news?id=009cffeba796b0cd92a7f577f44675e4a6474c589b378945b3f43df27251528b
company,1612137600,Resumen: Gran ensayo clínico presentado en STS 2021 revela una tasa de supervivencia del 79 % tras el uso de Impella 5.5 con SmartAssist,62630432,https://mms.businesswire.com/media/20210201005696/es/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) anuncia que un gran estudio con 356 pacientes tratados con Impella 5.5 con SmartAssist en 16 centros de EE. UU. y Alemania ha r,https://finnhub.io/api/news?id=c50e3d2395d26675afc3fb18bed4477d27ee446c04e48458b66fc8df39d7dce5
company,1612137600,"Global Cardiac Pacemakers Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com",62624222,https://mms.businesswire.com/media/20210201005547/en/371054/23/ResearchAndMarkets_800px.jpg,ABMD,businesswire,The,https://finnhub.io/api/news?id=5b034d693d11191f38dc35d39b3b19eb9dd7f17849aeeae14f60c7d6ae582c13
company,1612137600,Auf der STS-Jahrestagung vorgestellte umfangreiche klinische Studie zeigt Überlebensrate von 79 % bei Behandlung mit Impella 5.5 mit SmartAssist Herzpumpe,62623769,https://mms.businesswire.com/media/20210201005530/de/855170/23/Impella_Heart.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) hat die Ergebnisse aus einer umfangreichen klinischen Studie mit 356 Patienten vorgestellt, die an 16 US-amerikanischen und deu",https://finnhub.io/api/news?id=88412851916e66067fd542154d561d22b150984576fa5286b4e4cc934ebe7bd6
company,1612137600,Auf der STS-Jahrestagung vorgestellte umfangreiche klinische Studie zeigt Überlebensrate von 79 % bei Behandlung mit Impella 5.5 mit SmartAssist Herzpumpe,62623767,https://mms.businesswire.com/media/20210201005530/de/855170/23/Impella_Heart.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) hat die Ergebnisse aus einer umfangreichen klinischen Studie mit 356 Patienten vorgestellt, die an 16 US-amerikanischen und deu",https://finnhub.io/api/news?id=c73c2a81b27a0cc1b3603cd98f9e2710cfb2204db4781bfb5887557e9f5f0826
company,1612137600,Auf der STS-Jahrestagung vorgestellte umfangreiche klinische Studie zeigt Überlebensrate von 79 % bei Behandlung mit Impella 5.5 mit SmartAssist Herzpumpe,62623766,https://mms.businesswire.com/media/20210201005530/de/855170/23/Impella_Heart.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) hat die Ergebnisse aus einer umfangreichen klinischen Studie mit 356 Patienten vorgestellt, die an 16 US-amerikanischen und deu",https://finnhub.io/api/news?id=a253e6d5ef1044cce38e16b19d17880bc6675370497ba95120d64e5f9a51f039
company,1612137600,Auf der STS-Jahrestagung vorgestellte umfangreiche klinische Studie zeigt Überlebensrate von 79 % bei Behandlung mit Impella 5.5 mit SmartAssist Herzpumpe,62622937,https://mms.businesswire.com/media/20210201005530/de/855170/23/Impella_Heart.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) hat die Ergebnisse aus einer umfangreichen klinischen Studie mit 356 Patienten vorgestellt, die an 16 US-amerikanischen und deu",https://finnhub.io/api/news?id=545bcbd020c9252225ca76022cdaeb9ed1e977c24f4885639ca9b89ca304eac0
company,1612078231,UK charity shops hope donation surge will help cover lockdown losses,62616989,https://i.guim.co.uk/img/media/e5732385000ab2e58864b736d2a3891023bdf409/36_42_2488_1494/master/2488.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdG8tZGVmYXVsdC5wbmc&enable=upscale&s=f4df31e23d31c51858cd290087dd829e,ABMD,The Guardian,"Closed stores have cost charities more than £28m a month, but once Covid restrictions are eased bosses hope for a spring boost",https://finnhub.io/api/news?id=ff26ce0cc10466b1c11f4f7b0a9839ce12a4261c4e6feb12d0a452614d3392ef
company,1612054900,"Abiomed, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions",63475815,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?613823093,ABMD,Nasdaq,"Abiomed, Inc. (NASDAQ:ABMD) just released its quarterly report and things are looking bullish.      It was overall a positive result, with revenues beating expectations by 2.4% to hit US$232m. Abiomed also reported a statutory profit of US$1.35, which was an impressive 20% above",https://finnhub.io/api/news?id=ce93f9f770ab5faede67268fd712479b357e207edc51ef87262248f99c35e595
company,1611964800,Une vaste étude clinique présentée lors de la réunion annuelle 2021 de la Society of Thoracic Surgeons (STS) conclut que l'utilisation de la pompe cardiaque Impella 5.5 avec SmartAssist est associée à un taux de survie de 79%,62609381,https://mms.businesswire.com/media/20210129005650/fr/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annonce qu'une vaste étude réunissant 356 patients traités avec la pompe cardiaque Impella 5.5 avec SmartAssist dans 16 centres,https://finnhub.io/api/news?id=fecfdf78452c95062340c820aac146e509644b7e51e8067e5076073d78faecd6
company,1611964800,Une vaste étude clinique présentée lors de la réunion annuelle 2021 de la Society of Thoracic Surgeons (STS) conclut que l'utilisation de la pompe cardiaque Impella 5.5 avec SmartAssist est associée à un taux de survie de 79%,62609379,https://mms.businesswire.com/media/20210129005650/fr/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annonce qu'une vaste étude réunissant 356 patients traités avec la pompe cardiaque Impella 5.5 avec SmartAssist dans 16 centres,https://finnhub.io/api/news?id=ff6f4c295b1a294445d881d0280779c8552951ea30b9b7d91ff604f0b477ef6e
company,1611964800,Une vaste étude clinique présentée lors de la réunion annuelle 2021 de la Society of Thoracic Surgeons (STS) conclut que l'utilisation de la pompe cardiaque Impella 5.5 avec SmartAssist est associée à un taux de survie de 79%,62609377,https://mms.businesswire.com/media/20210129005650/fr/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annonce qu'une vaste étude réunissant 356 patients traités avec la pompe cardiaque Impella 5.5 avec SmartAssist dans 16 centres,https://finnhub.io/api/news?id=40041022f389423ae0e35a3c15bfdb8a2ad56e085af6cbf444f274b8cc45cfdc
company,1611964800,Une vaste étude clinique présentée lors de la réunion annuelle 2021 de la Society of Thoracic Surgeons (STS) conclut que l'utilisation de la pompe cardiaque Impella 5.5 avec SmartAssist est associée à un taux de survie de 79%,62609150,https://mms.businesswire.com/media/20210129005650/fr/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annonce qu'une vaste étude réunissant 356 patients traités avec la pompe cardiaque Impella 5.5 avec SmartAssist dans 16 centres,https://finnhub.io/api/news?id=9cbf99982b0576cc89dba5a7efacd5d6b9b84a85c975b5df7933b7b3c4a0607e
company,1611939480,"Abiomed Inc. stock falls Friday, underperforms market",62607197,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 1.94% to $348.25 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=9e4b2a94bfcc9d11cb5a6c583720c617252ac639df3471ec1f8db4764c75bb80
company,1611878400,"The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO",62600631,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_306.jpg,ABMD,benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 28)

Abbott Laboratories (NYSE:...",https://finnhub.io/api/news?id=c120b27070687e58d8f319636fa7de15e80c6524a7f606e0dd8b07fdc035d1b6
company,1611878400,Riassunto: Un ampio studio clinico presentato all'STS 2021 rivela un tasso di sopravvivenza del 79% con Impella 5.5 con SmartAssist,62607978,https://mms.businesswire.com/media/20210129005636/it/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annuncia che un ampio studio condotto su 356 pazienti trattati con Impella 5.5 con SmartAssist presso 16 centri negli USA e in,https://finnhub.io/api/news?id=5bc08313628b0a1f2205b64cbe33e9fabd1efa7e4916417d5628f2905cdccdcf
company,1611878400,Riassunto: Un ampio studio clinico presentato all'STS 2021 rivela un tasso di sopravvivenza del 79% con Impella 5.5 con SmartAssist,62607977,https://mms.businesswire.com/media/20210129005636/it/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annuncia che un ampio studio condotto su 356 pazienti trattati con Impella 5.5 con SmartAssist presso 16 centri negli USA e in,https://finnhub.io/api/news?id=9dff36c798fadb08884ce9c70b89821be1abbe85a66c1f0a4bc69978893892e7
company,1611878400,Riassunto: Un ampio studio clinico presentato all'STS 2021 rivela un tasso di sopravvivenza del 79% con Impella 5.5 con SmartAssist,62607976,https://mms.businesswire.com/media/20210129005636/it/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annuncia che un ampio studio condotto su 356 pazienti trattati con Impella 5.5 con SmartAssist presso 16 centri negli USA e in,https://finnhub.io/api/news?id=5c052a7912f57ab546448f2d0d45f395f9e46a2db9f2921e97d26cb80053278b
company,1611878400,Riassunto: Un ampio studio clinico presentato all'STS 2021 rivela un tasso di sopravvivenza del 79% con Impella 5.5 con SmartAssist,62607751,https://mms.businesswire.com/media/20210129005636/it/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) annuncia che un ampio studio condotto su 356 pazienti trattati con Impella 5.5 con SmartAssist presso 16 centri negli USA e in,https://finnhub.io/api/news?id=e9686f8bf2c909d5007606fda923fcf1d48ab82e46294f8b609c34023768a8ba
company,1611878400,Samenvatting: Grote klinische studie gepresenteerd op STS 2021 vindt 79% overlevingspercentage met Impella 5.5 met SmartAssist,62602601,https://mms.businesswire.com/media/20210129005516/nl/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) kondigt een grote studie aan onder 356 patiënten die werden behandeld met Impella 5.5 met SmartAssist in 16 Amerikaanse en Duit,https://finnhub.io/api/news?id=c4101f0b8c701a5e530cc9638a6b2d8446581d2d86f823aa9c3a3e997fe6ac46
company,1611878400,"Global Cardiac Monitoring Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com",62596506,https://mms.businesswire.com/media/20210129005347/en/371054/23/ResearchAndMarkets_800px.jpg,ABMD,businesswire,The,https://finnhub.io/api/news?id=33a4b997477d3137f99e682aee07a2558e365b795b281ef45e40808190923fbf
company,1611878400,Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist,62596493,https://mms.businesswire.com/media/20210129005016/en/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) announces a large study of 356 patients treated with Impella 5.5 with SmartAssist at 16 U.S. and German centers found a 79% sur,https://finnhub.io/api/news?id=d6967ba64b9b758e30928d6508f6be84e6ba50cf69c5d217891fac668e34a1fe
company,1611878400,Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist,62596491,https://mms.businesswire.com/media/20210129005016/en/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) announces a large study of 356 patients treated with Impella 5.5 with SmartAssist at 16 U.S. and German centers found a 79% sur,https://finnhub.io/api/news?id=09422b9740179ea9382df4f869d5278176d50f8fdb7ed20033ac9beb52d02743
company,1611878400,Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist,62596489,https://mms.businesswire.com/media/20210129005016/en/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) announces a large study of 356 patients treated with Impella 5.5 with SmartAssist at 16 U.S. and German centers found a 79% sur,https://finnhub.io/api/news?id=fc0b9badef512f12f7e4c72d3d6e34dabb940cb53e6a04e679a9f06f5bdafb10
company,1611878400,Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist,62596254,https://mms.businesswire.com/media/20210129005016/en/855170/23/Impella_Heart.jpg,ABMD,businesswire,Abiomed (NASDAQ: ABMD) announces a large study of 356 patients treated with Impella 5.5 with SmartAssist at 16 U.S. and German centers found a 79% sur,https://finnhub.io/api/news?id=efce4f465713a39ec330290e08f3b75a948bb42539a125556bc4f4403b23dd22
company,1611853080,Abiomed Inc. stock outperforms market on strong trading day,62586579,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 8.07% to $355.13 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=10404767caee579b01dd732ccba3a1bf0412b828d73e7de337ac32495f647bef
company,1611849331,"Health Care Sector Update for 01/28/2021: UBER,EYPT,ABMD,VCYT",63471717,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?415570854,ABMD,Nasdaq,"Health care stocks were ending mostly higher this afternoon, with the NYSE Health Care Index rising 2.0% while the SPDR Health Care Select Sector ETF also was up 1.9%.The Nasdaq Biotechnology index was climbing 0.6%.",https://finnhub.io/api/news?id=078b4d00941d50972819e41f05357f38c5145247937e32b97d89795bc23faf13
company,1611847214,"Abiomed, Inc. (ABMD) Q3 2021 Earnings Call Transcript | AlphaStreet",62580145,https://cdn.news.alphastreet.com/wp-content/uploads/2020/09/Transcript-thumbnail.jpg,ABMD,https://news.alphastreet.com,"Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021",https://finnhub.io/api/news?id=81a41c8fe1601c2077166f292d3aca48392d96a09d9f16f8e8aeda4279d61ba9
company,1611842077,"Health Care Sector Update for 01/28/2021: EYPT,ABMD,VCYT",63471720,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?698202894,ABMD,Nasdaq,"Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index rising 2.0% while the SPDR Health Care Select Sector ETF also was up 2.2%.The Nasdaq Biotechnology index was climbing 1.2%.",https://finnhub.io/api/news?id=4a1318294fd6c5beb94ebb31c26777a4743cd86f693a2ed26976d177aac56847
company,1611841860,Why Abiomed Stock Popped Today,63475818,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1584821370,ABMD,Nasdaq,"What happened?On Thursday morning, medical devices specialist Abiomed (NASDAQ: ABMD) released its financial reports for the third quarter of its fiscal year 2021, which ended on Dec. 31, 2020. Investors seem to be happy with the company's performance during this quarter: Abiomed'",https://finnhub.io/api/news?id=1158db01060134d66b4b79f4588c8866793a8b6093bb5814c1eb9f87f0ba6555
company,1611840669,Abiomed Inc (ABMD) Q3 2021 Earnings Call Transcript,63475819,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1758737758,ABMD,Nasdaq,Image source: The Motley Fool.,https://finnhub.io/api/news?id=f98bcdbfa77db1cc2a6adc00b58a8ad6d8058b85ae3ff696dc20f82d44573240
company,1611831600,"Quebec researchers find possible coronavirus treatment, but some remain skeptical",62589159,https://www.theglobeandmail.com/resizer/atTS3GLuNLcxdHCGOykTM8jplP4=/1200x0/filters:quality(80)/cloudfront-us-east-1.images.arcpublishing.com/tgam/6XVQCHNESJKZNKGLMYGZOZG7DM.jpg,ABMD,https://www.theglobeandmail.com,The data from a clinical trial has yet to be peer reviewed and some experts say more proof is needed,https://finnhub.io/api/news?id=41cb13f3069c9b8953f138bf2217c91cc638a477f40475dc37c6f99ccfffb50d
company,1611831001,"S&P 500 Movers: LUMN, AAL",64133774,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?772314320,ABMD,Nasdaq,"In early trading on Thursday, shares of American Airlines Group topped the list of the day's best performing components of the S&P 500 index, trading up 21.6%.  Year to date, American Airlines Group registers a 27.6% gain.",https://finnhub.io/api/news?id=e89192f5debc1692795f95f71edabd28bac00fc77438ccb93c12a562c74d4dca
company,1611829560,Stocks That Hit 52-Week Highs On Thursday,62590620,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png,ABMD,Benzinga," 
 
On Thursday morning, 92 companies achieved new highs for the year.
Interesting Highlights:

Abbott Laboratories (NYSE:ABT) was the largest company by market cap to...",https://finnhub.io/api/news?id=6e3e2520e41fac52e30973079b4754d47238027ab603e75f5bb347612c5c971c
company,1611820980,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",62572729,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nerve-cell-2213009_1920_19.jpg,ABMD,Benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 27)

Abbott Laboratories (NYSE:...",https://finnhub.io/api/news?id=be6aa801127354ddbd0493cf90c45ee345d4fd5bdc28b08d0c7d058698f8c9dc
company,1611818448,Abiomed Inc. Q3 Income Retreats,63475820,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?102124331,ABMD,Nasdaq,"(RTTNews) - Abiomed Inc. (ABMD) released earnings for third quarter that declined from the same period last year.The company's earnings came in at $61.87 million, or $1.35 per share.  This compares with $69.22 million, or $1.51 per share, in last year's third quarter.",https://finnhub.io/api/news?id=bcb79663c70f70170be6d85afd3c5fbadf9814c0a66c18e8e8b3440ee679ec57
company,1611806820,"Earnings Scheduled For January 28, 2021",62572570,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/earnings_scheduled_1790.png,ABMD,Benzinga," 
Companies Reporting Before The Bell
• OSI Systems (NASDAQ:OSIS) is expected to report quarterly earnings at $1.14 per share on revenue of $272.66 million.
• GATX...",https://finnhub.io/api/news?id=4604d5303c559ddfb01d01d2814c871fb0c38d5192b94e68e24d747f1ef79af3
company,1611792000,Abiomed: Q3 Earnings Insights,62578687,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png,ABMD,benzinga,"Shares of Abiomed (NASDAQ:ABMD) were unchanged after the company reported Q3 results.
Quarterly Results
Earnings per share rose 20.54% year over year to $1.35, which beat...",https://finnhub.io/api/news?id=2474b5f668bf383c17d9939eaab9b1638b57544a82a501171ddd7987619b63f8
company,1611792000,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",62577225,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nerve-cell-2213009_1920_19.jpg,ABMD,benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 27)

Abbott Laboratories (NYSE:...",https://finnhub.io/api/news?id=58699c55fd905e36ec493479e02e0544dc2e9ccdd82401f3889f9a6a0d19a0fc
company,1611792000,Abiomed: Q3 Earnings Insights,62575976,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png,ABMD,benzinga,"Shares of Abiomed (NASDAQ:ABMD) were unchanged after the company reported Q3 results.
Quarterly Results
Earnings per share rose 20.54% year over year to $1.35, which beat...",https://finnhub.io/api/news?id=2c42f3c8a897cdb0b98ef05ad5ebb977f05b0e71dc5a38d3a01df0d25eb9fc49
company,1611766680,Abiomed Inc. stock underperforms Wednesday when compared to competitors,62564813,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 3.61% to $328.60 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=f68c74499986952af58b9fb697ccd83f98909a8e1cdba51662e881d58b30ee7c
company,1611680280,Abiomed Inc. stock underperforms Tuesday when compared to competitors,62533960,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 2.13% to $340.89 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=63f044dfc3065e123105c905eee6c3fc5bc5eff17e80de82bb4bda37dc290a03
company,1611593880,"Abiomed Inc. stock rises Monday, still underperforms market",62506346,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.12% higher to $348.32 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=a8d7bd35e567ca407075fdca8b53990985130cb34aa93076f9eb7b82934bc35a
company,1611532800,MagSafe and medical devices: Apple says keep them ‘a safe distance away’,62539508,https://images.idgesg.net/images/article/2020/10/iphone-12-magsafe-100862047-large.3x2.jpg,ABMD,https://www.macworld.com,"Apple posted a support document noting that magnetic interference is possible with medical devices, and that users should consult with their doctor.",https://finnhub.io/api/news?id=ecbc85ac8f6b5346eefc2669dfc8e46bdf209c8f8bf185634ea528e3d77c582d
company,1611453600,Rule Breaker Investing: 5 Stocks Rolled Up at Random,63487033,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?583932915,ABMD,Nasdaq,"Surely it's not possible to beat the market with a random roll of the dice! But what if we're dicing in a universe of great companies? What if we're randomizing Rule Breakers? In this episode of Rule Breaker Investing, Motley Fool co-founder David Gardner is eager to find this ou",https://finnhub.io/api/news?id=c27fc9548a17d34f946bb85ad56def21fbef2aaa17f8a6099502812754ec1502
company,1611360000,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",62538890,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/syringe-1884758_1920_36_1.jpg,ABMD,benzinga,"Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market strength.
Eli Lilly And Co (NYSE: LLY) was the...",https://finnhub.io/api/news?id=e9967f226ee7bde531f3307ba27a47d655f6b8ebe0be6f1a8b583576c77807c7
company,1611334680,"Abiomed Inc. stock falls Friday, still outperforms market",62484427,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slumped 0.19% to $347.90 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=729a0eca21c2ff7e9860fd96eee64501b30d56dab53fb14f2e2d55a681af235d
company,1611248280,Abiomed Inc. stock outperforms market on strong trading day,62462562,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.20% higher to $348.56 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=9a79e69f3569c328039ec4ab5f7df0c27b26cdea58f6df22ca91066521f0b941
company,1611216300,"The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping",62462025,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/brain-1787622_1920_57.jpg,ABMD,Benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 20)

10X Genomics Inc (...",https://finnhub.io/api/news?id=bad94e59b438779c4109208792a323663eb68e8f793e9d1f3eb2d037b83b2434
company,1611161880,Abiomed Inc. stock outperforms competitors on strong trading day,62442422,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 3.44% to $347.87 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=ceac42b81d1c160f752c735e5a6e77b964e320b09afb63235ac0287eea6d4a0d
company,1611127920,"The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",62462137,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_301.jpg,ABMD,Benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 19)

4D Molecular Therapeutics...",https://finnhub.io/api/news?id=76fe8eec73d4c09a9a7a5ccd8a4b1144513a9ae5e6d9d6c670501ab185939fb1
company,1611075180,"Abiomed Inc. stock rises Tuesday, outperforms market",62406256,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rose 2.00% to $336.30 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=42dec1df18b01067c342f8b2780ee90d574cdd8fd45485bd4eadc22e0fea3a35
company,1611014400,Impulse Dynamics anuncia primeiro paciente com insuficiência cardíaca tratado com terapia CCM (MCC - Modulação de Contratilidade Cardíaca) no Brasil,62390307,https://mms.businesswire.com/media/20210119005191/pt/780141/23/19-09-25_ID_Coporate_Logo_gray.jpg,ABMD,businesswire,"A Impulse Dynamics, empresa dedicada a ajudar profissionais de saúde a melhorar as vidas de pessoas com insuficiência cardíaca, anunciou hoje que o pr",https://finnhub.io/api/news?id=380afa865903429c503686941f7aae78c3188034fdded5f06727a7acbedb448e
company,1610877600,Validea's Top Five Healthcare Stocks Based On David Dreman - 1/17/2021,63475821,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?769180629,ABMD,Nasdaq,The following are the top rated Healthcare stocks according to Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.CATAL,https://finnhub.io/api/news?id=3616aa1d403cac6551475eb98288289136ff08324e1764460a97466daccbac31
company,1610735340,Abiomed Inc. stock outperforms market on strong trading day,62376303,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 3.58% to $329.69 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=5b2ae15fed318240c0a953f8d7c71d01e4ec781fde2f6ad5ea2be02358b39ca9
company,1610721238,"Friday Sector Leaders: Utilities, Healthcare",63475822,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?2131162664,ABMD,Nasdaq,"In afternoon trading on Friday, Utilities stocks are the best performing sector, higher by 1.0%.  Within that group, NiSource Inc.  (Symbol: NI) and CenterPoint Energy, Inc (Symbol: CNP) are two large stocks leading the way, showing a gain of 4.3% and 2.9%, respectively.  Among",https://finnhub.io/api/news?id=d49e5e0390e1ec8d86277270ff35f5e42808e49e472f29c85e5deb3bd9baa19b
company,1610704800,Validea Peter Lynch Strategy Daily Upgrade Report - 1/15/2021,63604505,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?589303316,ABMD,Nasdaq,The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.MAGYAR TELEKOM TAVKOZLESI NY,https://finnhub.io/api/news?id=8a089340fe2d5740d8718f65f29885ac2f6677c4512fec56fea19b7f82cafd45
company,1610648940,Abiomed Inc. stock underperforms Thursday when compared to competitors,62350397,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 1.67% to $318.31 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=b7aae92636fec57df829f756f84f82a1bec41be237ffa7ba8dbe30601d9d169d
company,1610562600,"Abiomed Inc. stock falls Wednesday, underperforms market",62330102,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slipped 0.30% to $323.71 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=f06ccb400bf7ebcf294ccad9c1d7e26b7c8bf01ae153aff4e952d08a879bf44e
company,1610476140,"Abiomed Inc. stock rises Tuesday, still underperforms market",62300312,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.02% higher to $324.67 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=f0ad3dc97c8882c16dbfaefcf0b380b4b1f3e7083ec6d422a43baadafb3777f0
company,1610389800,Abiomed Inc. stock outperforms competitors on strong trading day,62269481,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.16% higher to $324.59 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=fb2cf2fd727d095db64cd8f52273bbf9913eecd4cadc41d8f21502b3912e07f6
company,1610130540,"Abiomed Inc. stock rises Friday, still underperforms market",62235276,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.15% higher to $324.06 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=f80cf4b61ce3d268b2f249d63bf8ffa97e7f9bfb4cb98abdfccc2e70e19dc595
company,1610064000,Abiomed setzt die Stärkung seines geistigen Eigentums fort und hält nun bereits Rechte an über 1.000 Patenten,62226401,https://mms.businesswire.com/media/20210108005347/de/722993/23/AbioLogo_TAGLINE_COLOR.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) gibt bekannt, dass das Unternehmen über mehr als 1.000 Patente und 850 angemeldete Patente weltweit verfügt. Das robuste Portfo",https://finnhub.io/api/news?id=77b342a1e1a5ba8d54fdc2c8bcb1f0849832e8bfc9c9824a8db042636bd9f925
company,1610044200,"Abiomed Inc. stock rises Thursday, still underperforms market",62214719,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.61% higher to $323.56 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=8f06cfb64eecc16ed32d5ee92ef665dfe5ffb42925b35fdad0f6f465a8fc692d
company,1609977600,"Riassunto: Abiomed continua a rafforzare la sua proprietà intellettuale, ora detiene più di 1.000 brevetti",62201991,https://mms.businesswire.com/media/20210107005721/it/722993/23/AbioLogo_TAGLINE_COLOR.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) annuncia di aver superato più di 1.000 brevetti in tutto il mondo, con oltre 850 ulteriori brevetti in corso di registrazione.",https://finnhub.io/api/news?id=25f21b3633c9fa8588413b8f543280a5dd76a353895218d4e21fd52327c5a95d
company,1609977600,Samenvatting: Abiomed blijft haar intellectuele eigendom versterken en bezit nu meer dan 1.000 patenten,62198208,https://mms.businesswire.com/media/20210107005660/nl/722993/23/AbioLogo_TAGLINE_COLOR.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) kondigt aan dat het wereldwijd meer dan 1.000 patenten heeft overtroffen, met meer dan 850 aangevraagde patenten. Abiomeds robu",https://finnhub.io/api/news?id=40165ef50d6bd770c78c18676693b23cf2364604ccdc8b8dfbefc623a8ea3448
company,1609977600,Abiomed continue de renforcer sa propriété intellectuelle et détient à présent plus de 1 000 brevets,62198205,https://mms.businesswire.com/media/20210107005665/fr/722993/23/AbioLogo_TAGLINE_COLOR.jpg,ABMD,businesswire,"Abiomed (NASDAQ : ABMD) annonce avoir dépassé le cap des 1 000 brevets au niveau mondial, et compte plus de 850 brevets en instance supplémentaires. L",https://finnhub.io/api/news?id=43a456e43b2da6dbcfc45b748a5e93213079f2d0342f5992b2ed923bcf7eba3f
company,1609977600,"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents",62193098,https://mms.businesswire.com/media/20210107005146/en/722993/23/AbioLogo_TAGLINE_COLOR.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed’s robust i",https://finnhub.io/api/news?id=86f868eb30c3c3ca55711435a482ae4bd0337bf8c2de3d84c4db5f8a61d9f324
company,1609957740,"Abiomed Inc. stock falls Wednesday, underperforms market",62182567,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. shed 0.31% to $321.61 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=87b9421ed82caa54f63db390489662ad3a30c20bf04efd3327634200713cae28
company,1609871400,Abiomed Inc. stock outperforms market on strong trading day,62155024,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 1.85% to $322.60 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=709c56c62b74dfd6dbeadbd75ed8f98ae2114606f505c76025fbf78edb78a603
company,1609835880,"The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data",62154228,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/red-blood-cells-3188223_1920_18.jpg,ABMD,Benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 4)

ABIOMED, Inc. (NASDAQ: ABMD...",https://finnhub.io/api/news?id=1d2f2353b8b1d9b4b90e155aa00aea037197901b783a8ef63a0a94ee25682c2b
company,1609784760,"Abiomed Inc. stock falls Monday, underperforms market",62135817,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. slid 2.30% to $316.73 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=fb1ba30e6ca0153af3fd47317ff4294495921e279d4a0370fd227204f1a19b15
company,1609765020,Stocks That Hit 52-Week Highs On Monday,62135288,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png,ABMD,Benzinga," 
During Monday's morning session, 286 stocks hit new 52-week highs.
Areas of Interest:

The company with the largest market cap to set a new 52-week high was Tesla (...",https://finnhub.io/api/news?id=7e294fb973473add652290afef1d64bb4821daf6562b0c7a2d728c83fa053b4f
company,1609565443,"Andrew J. Greenfield Sells 5,000 Shares of Abiomed, Inc. (NASDAQ:ABMD) Stock",62102377,https://www.marketbeat.com/logos/abiomed-logo.gif,ABMD,https://www.thelincolnianonline.com,"Abiomed, Inc. (NASDAQ:ABMD) VP Andrew J. Greenfield sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 29th. The shares were sold at an average price of $321.00, for a total value of $1,605,000.00. Following the completion of the transaction, the vice president now owns 26,930 shares of the company’s […]",https://finnhub.io/api/news?id=e81ac582ab6f44ac1207de7f40e7414531e1cd338d88befd5f6fcf524fdc8963
company,1609439340,"Abiomed Inc. stock rises Thursday, still underperforms market",62081895,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.09% higher to $324.20 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...",https://finnhub.io/api/news?id=1bf63abf7fb4aa4bc9bb4fb2b4de7c1eed91c4554c7fd36d5bd1a9cc711cd06a
company,1609352940,Abiomed Inc. stock outperforms market on strong trading day,62061521,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.93% higher to $323.92 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...",https://finnhub.io/api/news?id=514a4f757c1aec52b281dbc20e4fc7c0006c7db8524a8f24d9f5605c697fe719
company,1609323660,Stocks That Hit 52-Week Highs On Wednesday,62060976,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png,ABMD,Benzinga," 
Wednesday morning saw 123 companies set new 52-week highs.
Areas of Significance:

The largest company by market cap to break to a new 52-week high was Taiwan Semiconductor...",https://finnhub.io/api/news?id=ae9136bd883a2f0939df6ddc7d2ccd5a379a657146985c2fe8ea9f70588d9994
company,1609315680,"The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data",62060980,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/dna-24559_1280_26.png,ABMD,Benzinga,"Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Dec. 29)

ABIOMED, Inc. (NASDAQ: ABMD...",https://finnhub.io/api/news?id=29f90a1ebf37e89dae203d78ca4ae8be3c4cd0f6b8bad8d3331b5dab56dc98fb
company,1609266600,Abiomed Inc. stock outperforms competitors on strong trading day,62041554,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. rallied 2.56% to $320.93 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...",https://finnhub.io/api/news?id=a005be01972883c19ac48d27bfd23b506b5c5e1c3f0521df501358ed330dda0a
company,1609256369,"Tuesday Sector Leaders: Healthcare, Utilities",62044902,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?622864065,ABMD,Nasdaq,"Looking at the sectors faring best as of midday Tuesday, shares of Healthcare companies are outperforming other sectors, not showing much of a loss.  Within that group, ABIOMED, Inc. (Symbol: ABMD) and Zimmer Biomet Holdings Inc (Symbol: ZBH) are two large stocks leading the wa",https://finnhub.io/api/news?id=fe2435a787bae365d2e2cb8af7a7cf637d9831a0ea2980fe5744c7fb207e551d
company,1609255200,These are the best performing Nasdaq and S&P 500 stocks of 2020,62032952,https://s.marketwatch.com/public/resources/images/MW-IX074_tesla__ZG_20201228113827.jpg,ABMD,MarketWatch,COVID-19 has rewarded companies at the cutting edge of mobility and remote working.,https://finnhub.io/api/news?id=88cb9befaa833b8fed137f76c4c2e332025cb96bc92458b5a1032a6d2ae0340d
company,1609241236,"BUZZ-U.S. STOCKS ON THE MOVE-Amphastar Pharma, Snap, Aprea Therapeutics",62039916,https://www.nasdaq.com/sites/acquia.prod/files/2020-11-09T194226Z_892677665_RC2VZJ9Q6HBA_RTRMADP_2_USA-STOCKS.JPG?1577077819,ABMD,Nasdaq,"A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string ""STXBZ US"" and Thomson One users please search ""RT/STXBZ US"".",https://finnhub.io/api/news?id=b4ad623c4a8653f35ff9c8e1be1c3938e13efd869559a0fffeb8725eba502fa4
company,1609239987,"S&P 500 Movers: LB, ABMD",62039978,https://www.nasdaq.com/sites/acquia.prod/files/2019-05/0902-Q19%20Total%20Markets%20photos%20and%20gif_CC8.jpg?1796165826,ABMD,Nasdaq,"In early trading on Tuesday, shares of ABIOMED, topped the list of the day's best performing components of the S&P 500 index, trading up 2.7%.  Year to date, ABIOMED, registers a 88.4% gain.",https://finnhub.io/api/news?id=80fd47e38b796ebf3cd282131946cea2391d7d064c67f64e1a436973cbde1036
company,1609237920,Stocks That Hit 52-Week Highs On Tuesday,62040135,https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png,ABMD,Benzinga," 
This morning 110 companies set new 52-week highs.
Interesting Facts:

Apple (NASDAQ: AAPL) was the company with the largest market cap to set a new 52-week high.
New...",https://finnhub.io/api/news?id=43bcff740e81dc1851ab9c1c7f825e63d649fe8eae96ffa08c998f22f5fc75d0
company,1609180140,"Abiomed Inc. stock rises Monday, outperforms market",62023735,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 3.13% to $312.91 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=70490cb63633b959b87867e06e0a07cf3afa9a9bb317dad7923bbc9706ec00cd
company,1608852600,"Abiomed Inc. stock falls Thursday, underperforms market",61999262,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. sank 0.21% to $303.41 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=423f1cf54ae759350cfa923fc6130bc4b78983962f4c502b1cd4d90f7cd6146c
company,1608748140,Abiomed Inc. stock outperforms competitors on strong trading day,61951866,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.57% higher to $304.05 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...",https://finnhub.io/api/news?id=8c0706b08535b38a9bb2bc830f741584adf8e0ca81f86cb46bc7ad9114e8edff
company,1608661800,Abiomed Inc. stock outperforms competitors on strong trading day,61835791,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 2.20% to $302.33 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=08030652300da8214d40eda39fa3f263a1cf7e15d08734aec4bd409b7ff6f0e1
company,1608575400,Abiomed Inc. stock outperforms competitors on strong trading day,61812912,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. inched 0.82% higher to $295.81 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",https://finnhub.io/api/news?id=23af7f86d5dd091d251439e39a07f223c56050b250b6f17200572f5b992c9732
company,1608508800,"Riassunto: I primi pazienti, compreso un paziente COVID-19, trattati con la tecnologia innovativa ECMO di Abiomed",61808426,https://mms.businesswire.com/media/20201221005692/it/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) annuncia il trattamento dei primi due pazienti al mondo con Abiomed Breethe OXY-1 System, un sistema compatto di bypass cardiop",https://finnhub.io/api/news?id=749d50d39c46495d65170ef1b342d53225bd5f35a2f98ea3fa8fb7a8172d4503
company,1608508800,"Deux premières patientes, dont une atteinte de la COVID-19, ont été traitées avec ECMO, la technologie innovante d’Abiomed",61808390,https://mms.businesswire.com/media/20201221005680/fr/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) annonce que, pour la première fois au monde, deux patientes ont été traitées avec l'Abiomed Breethe OXY-1 , un système de ponta",https://finnhub.io/api/news?id=b0216e306abba8db7b37f073e9441751512647b3da278b2d65a9881f3b11ca9d
company,1608508800,"Deux premières patientes, dont une atteinte de la COVID-19, ont été traitées avec ECMO, la technologie innovante d’Abiomed",61808389,https://mms.businesswire.com/media/20201221005680/fr/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) annonce que, pour la première fois au monde, deux patientes ont été traitées avec l'Abiomed Breethe OXY-1 , un système de ponta",https://finnhub.io/api/news?id=23dea1ace8e5fa3b31d2d1bd55461efdeffc705599fb2fb71c23c763ae78c7cd
company,1608508800,"Deux premières patientes, dont une atteinte de la COVID-19, ont été traitées avec ECMO, la technologie innovante d’Abiomed",61808388,https://mms.businesswire.com/media/20201221005680/fr/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) annonce que, pour la première fois au monde, deux patientes ont été traitées avec l'Abiomed Breethe OXY-1 , un système de ponta",https://finnhub.io/api/news?id=190b39a672864dd82e9bf9965eb0c6c68510322b8d78213ca92914fe19317898
company,1608508800,"Deux premières patientes, dont une atteinte de la COVID-19, ont été traitées avec ECMO, la technologie innovante d’Abiomed",61808333,https://mms.businesswire.com/media/20201221005680/fr/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) annonce que, pour la première fois au monde, deux patientes ont été traitées avec l'Abiomed Breethe OXY-1 , un système de ponta",https://finnhub.io/api/news?id=5aa4f2017b3b8d139e46db98ca7fb52b768a360c55199dda9166e353a1a96909
company,1608508800,"Resumen: Los primeros pacientes, incluido un paciente de COVID-19, tratados con la innovadora tecnología ECMO de Abiomed",61804754,https://mms.businesswire.com/media/20201221005524/es/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) ha anunciado que los dos primeros pacientes en el mundo han sido tratados con el sistema Abiomed Breethe OXY-1, un sistema de b",https://finnhub.io/api/news?id=ead68b712339cb7e21b5c02a1b5673a11323a9271bf2a813de4b9b9711cdc672
company,1608508800,"Samenvatting: Eerste patiënten, waaronder een COVID-19-patiënt, behandeld met de innovatieve ECMO-technologie van Abiomed",61804752,https://mms.businesswire.com/media/20201221005521/nl/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) kondigt aan dat de eerste twee patiënten ter wereld zijn behandeld met het Abiomed Breethe OXY-1-systeem, een compact cardiopul",https://finnhub.io/api/news?id=570bbde46ef6802c3b04c1875bb6bd08b86dac87757c056e2537435c1dbba5cd
company,1608508800,"Samenvatting: Eerste patiënten, waaronder een COVID-19-patiënt, behandeld met de innovatieve ECMO-technologie van Abiomed",61804751,https://mms.businesswire.com/media/20201221005521/nl/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) kondigt aan dat de eerste twee patiënten ter wereld zijn behandeld met het Abiomed Breethe OXY-1-systeem, een compact cardiopul",https://finnhub.io/api/news?id=bd7ff6e593d458819919aa2f7f431a0eb8d11666907164c2d6fb90f4e9604c84
company,1608508800,"Samenvatting: Eerste patiënten, waaronder een COVID-19-patiënt, behandeld met de innovatieve ECMO-technologie van Abiomed",61804750,https://mms.businesswire.com/media/20201221005521/nl/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) kondigt aan dat de eerste twee patiënten ter wereld zijn behandeld met het Abiomed Breethe OXY-1-systeem, een compact cardiopul",https://finnhub.io/api/news?id=6c882ebc62c11f28246272f5be962640bea0201c0e74c73ac10e06d1ddb1a82e
company,1608508800,"Samenvatting: Eerste patiënten, waaronder een COVID-19-patiënt, behandeld met de innovatieve ECMO-technologie van Abiomed",61804740,https://mms.businesswire.com/media/20201221005521/nl/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"Abiomed (NASDAQ: ABMD) kondigt aan dat de eerste twee patiënten ter wereld zijn behandeld met het Abiomed Breethe OXY-1-systeem, een compact cardiopul",https://finnhub.io/api/news?id=94cff3da913ff21fb3d1a706aeeff0e69d19bf2cb5226185345fd0a2577e3fce
company,1608508800,"First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology",61803375,https://mms.businesswire.com/media/20201221005403/en/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"The first two patients in the world have been treated with the Abiomed Breethe OXY-1 System, including a COVID-19 patient in respiratory failure.",https://finnhub.io/api/news?id=254ce248e07c865f51120ba0a085bde998e3536f87951d393966faa0b4d4a9c6
company,1608508800,"First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology",61803374,https://mms.businesswire.com/media/20201221005403/en/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"The first two patients in the world have been treated with the Abiomed Breethe OXY-1 System, including a COVID-19 patient in respiratory failure.",https://finnhub.io/api/news?id=b77c5040f08f65381e2342be3629fd58d58e4c82e63487968b64fc2116a79a30
company,1608508800,"First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology",61803373,https://mms.businesswire.com/media/20201221005403/en/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"The first two patients in the world have been treated with the Abiomed Breethe OXY-1 System, including a COVID-19 patient in respiratory failure.",https://finnhub.io/api/news?id=011c77d556bd19938043fd18ba14c7caf9553e3fa949c2de318561669639f7bd
company,1608508800,"First Patients, Including a COVID-19 Patient, Treated with Abiomed’s Innovative ECMO Technology",61803260,https://mms.businesswire.com/media/20201221005403/en/848312/23/First_Patient_Ambulating.jpg,ABMD,businesswire,"The first two patients in the world have been treated with the Abiomed Breethe OXY-1 System, including a COVID-19 patient in respiratory failure.",https://finnhub.io/api/news?id=a7376bf6372faa9c31e02632dcd38f416381af58fc233b06f22217085a5e5f9b
company,1608316320,Abiomed Inc. stock outperforms market on strong trading day,61792805,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 4.04% to $293.39 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=ab0261a471ddc336491d9b4aa78ea1497dcf5089a90c333c31b0d9877a65c787
company,1608229740,"Abiomed Inc. stock rises Thursday, outperforms market",61777840,https://images.mktw.net/im-220105/social,ABMD,MarketWatch,"Shares of Abiomed Inc. advanced 2.86% to $281.99 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...",https://finnhub.io/api/news?id=180d3ab5ad4c04d0738842567c55bce6bcccaf59d33e7263dbd6b665c950a242
company,1608187846,"Brinker Capital Investments LLC Takes $2.72 Million Position in Abiomed, Inc. (NASDAQ:ABMD)",61773122,https://www.marketbeat.com/logos/abiomed-logo.gif,ABMD,https://www.thelincolnianonline.com,"Brinker Capital Investments LLC bought a new stake in shares of Abiomed, Inc. (NASDAQ:ABMD) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 9,810 shares of the medical equipment provider’s stock, valued at approximately $2,718,000. Other large investors also recently made changes […]",https://finnhub.io/api/news?id=01f52cec9e9d682737c2f5100d1a2b54d2cae299a4bb6c7275dc04f57e96b862
